• FindZebra
  • About
  • Contact
  • Help
  • Login
Advanced
  • Carney Complex Wikipedia
    Carney complex Other names LAMB syndrome Specialty Oncology , cardiology Carney complex and its subsets LAMB syndrome [1] and NAME syndrome [1] are autosomal dominant conditions comprising myxomas of the heart and skin, hyperpigmentation of the skin ( lentiginosis ), and endocrine overactivity. [2] [3] It is distinct from Carney's triad . ... Endocrine tumors may manifest as disorders such as Cushing syndrome . The most common endocrine gland manifestation is an ACTH-independent Cushing's syndrome due to primary pigmented nodular adrenocortical disease (PPNAD). The LAMB acronym refers to lentigines , atrial myxomas , and blue nevi . [1] NAME refers to nevi , atrial myxoma, myxoid neurofibromas, and ephelides . [1] Testicular cancer, particularly Sertoli cell type, is associated with Carney syndrome. [5] Thyroid and pancreas cancer may also occur. [6] [7] Although J Aidan Carney also described Carney's triad it is entirely different. [8] Pathophysiology [ edit ] Carney complex is most commonly caused by mutations in the PRKAR1A gene on chromosome 17 (17q23-q24) [9] which may function as a tumor-suppressor gene . ... See also [ edit ] Epithelioid blue nevus List of cutaneous neoplasms associated with systemic syndromes References [ edit ] ^ a b c d Carney Syndrome at eMedicine ^ Carney, J.; Gordon, H.; Carpenter, P.; Shenoy, B.; Go, V. (1985). ... J Endocr Soc 1(10):1312-1321. doi: 10.1210/js.2017-00283 External links [ edit ] Classification D OMIM : 160980 605244 MeSH : D056733 External resources eMedicine : med/2941 Orphanet : 1359 GeneReview/UW/NIH entry on Carney complex v t e Deficiencies of intracellular signaling peptides and proteins GTP-binding protein regulators GTPase-activating protein Neurofibromatosis type I Watson syndrome Tuberous sclerosis Guanine nucleotide exchange factor Marinesco–Sjögren syndrome Aarskog–Scott syndrome Juvenile primary lateral sclerosis X-Linked mental retardation 1 G protein Heterotrimeic cAMP / GNAS1 : Pseudopseudohypoparathyroidism Progressive osseous heteroplasia Pseudohypoparathyroidism Albright's hereditary osteodystrophy McCune–Albright syndrome CGL 2 Monomeric RAS: HRAS Costello syndrome KRAS Noonan syndrome 3 KRAS Cardiofaciocutaneous syndrome RAB: RAB7 Charcot–Marie–Tooth disease RAB23 Carpenter syndrome RAB27 Griscelli syndrome type 2 RHO: RAC2 Neutrophil immunodeficiency syndrome ARF : SAR1B Chylomicron retention disease ARL13B Joubert syndrome 8 ARL6 Bardet–Biedl syndrome 3 MAP kinase Cardiofaciocutaneous syndrome Other kinase / phosphatase Tyrosine kinase BTK X-linked agammaglobulinemia ZAP70 ZAP70 deficiency Serine/threonine kinase RPS6KA3 Coffin-Lowry syndrome CHEK2 Li-Fraumeni syndrome 2 IKBKG Incontinentia pigmenti STK11 Peutz–Jeghers syndrome DMPK Myotonic dystrophy 1 ATR Seckel syndrome 1 GRK1 Oguchi disease 2 WNK4 / WNK1 Pseudohypoaldosteronism 2 Tyrosine phosphatase PTEN Bannayan–Riley–Ruvalcaba syndrome Lhermitte–Duclos disease Cowden syndrome Proteus-like syndrome MTM1 X-linked myotubular myopathy PTPN11 Noonan syndrome 1 LEOPARD syndrome Metachondromatosis Signal transducing adaptor proteins EDARADD EDARADD Hypohidrotic ectodermal dysplasia SH3BP2 Cherubism LDB3 Zaspopathy Other NF2 Neurofibromatosis type II NOTCH3 CADASIL PRKAR1A Carney complex PRKAG2 Wolff–Parkinson–White syndrome PRKCSH PRKCSH Polycystic liver disease XIAP XIAP2 See also intracellular signaling peptides and proteins
    PRKAR1A
    • Carney Complex Gard
      Carney complex is an inherited condition characterized by spotty skin pigmentation, cardiac (heart) myxomas (tumors composed of mucous connective tissue), skin myxomas, endocrine tumors or over-activity, and schwannomas . Some families with this condition have been found to have mutations in the PRKAR1A gene. Carney complex is believed to be inherited in an autosomal dominant manner, which means that one copy of the altered gene in each cell is sufficient to cause the disorder. In most cases, an affected person inherits the mutation from one affected parent.
    • Carney Complex Medlineplus
      High levels of cortisol (hypercortisolism) can lead to the development of Cushing syndrome. This syndrome causes weight gain in the face and upper body, slowed growth in children, fragile skin, fatigue, and other health problems.
    • Carney Complex, Type 2 Omim
      Skin myxomas, cardiac myxomas, Cushing syndrome, and acromegaly were present in, respectively, 62%, 30%, 31%, and 8% of the patients. ... Endocrine abnormalities were present in 3, 2 showed thyroid dysfunction, and 1 required adrenalectomy for Cushing syndrome. Linkage studies yielded lod scores of less than -2.0 over the 10-cM interval between D2S391 and D2S393, where the Carney complex had previously been mapped by Stratakis et al. (1996).
    • Carney Complex, Type 1 Omim
      Schweizer-Cagianut et al. (1982) concluded that the family had a syndrome comprising adrenocortical nodular dysplasia, Cushing syndrome, and myxomatous tumors. ... Loss of Heterozygosity Studies Stratakis et al. (1998) noted that the lesions in patients with CNC are similar to those seen in Peutz-Jeghers syndrome and other lentiginosis syndromes. In tumors and cell lines from 2 CNC families excluded from the CNC2 locus, Stratakis et al. (1998) found no evidence for loss of heterozygosity (LOH) involving the Peutz-Jeghers syndrome locus on 19p13 (STK11; 602216) or Cowden syndrome (158350) locus on 10q23 (PTEN; 601728). Studies of 16 additional CNC patients also did not show LOH at these loci in tumors that were histologically identical to those seen in Peutz-Jeghers syndrome. The authors concluded that despite substantial clinical overlap among CNC, Peutz-Jeghers syndrome, and Cowden disease, LOH for the STK11 and PTEN loci is an infrequent event in CNC-related tumors. ... Nomenclature Carney et al. (1985) suggested that the acronym NAME syndrome, as well as the acronym LAMB syndrome (lentigines, atrial myxoma, mucocutaneous myxoma, and blue nevi) reported by Rhodes et al. (1984), could represent this pleiotropic syndrome of cutaneous, cardiac, and endocrine involvement.
  • Neurofibromatosis Type Ii Wikipedia
    Type of neurofibromatosis disease Neurofibromatosis type II Other names multiple inherited schwannomas, meningiomas, and ependymomas (MISME syndrome)) Micrograph of a schwannoma , a tumor seen in neurofibromatosis type II. ... Specialty Medical genetics , neurology Neurofibromatosis type II (also known as MISME syndrome – multiple inherited schwannomas, meningiomas, and ependymomas) is a genetic condition which may be inherited or may arise spontaneously. ... External links [ edit ] Classification D ICD - 10 : D33 , Q85.0 ( ILDS Q85.020) ICD - 9-CM : 237.72 OMIM : 101000 MeSH : D016518 DiseasesDB : 8960 External resources MedlinePlus : 000795 eMedicine : neuro/496 radio/475 GeneReviews : Neurofibromatosis 2 v t e Phakomatosis Angiomatosis Sturge–Weber syndrome Von Hippel–Lindau disease Hamartoma Tuberous sclerosis Hypothalamic hamartoma ( Pallister–Hall syndrome ) Multiple hamartoma syndrome Proteus syndrome Cowden syndrome Bannayan–Riley–Ruvalcaba syndrome Lhermitte–Duclos disease Neurofibromatosis Type I Type II Other Abdallat–Davis–Farrage syndrome Ataxia telangiectasia Incontinentia pigmenti Peutz–Jeghers syndrome Encephalocraniocutaneous lipomatosis v t e Tumours of the nervous system Endocrine Sellar : Craniopharyngioma Pituicytoma Other: Pinealoma CNS Neuroepithelial ( brain tumors , spinal tumors ) Glioma Astrocyte Astrocytoma Pilocytic astrocytoma Pleomorphic xanthoastrocytoma Subependymal giant cell astrocytoma Fibrillary astrocytoma Anaplastic astrocytoma Glioblastoma multiforme Oligodendrocyte Oligodendroglioma Anaplastic oligodendroglioma Ependyma Ependymoma Subependymoma Choroid plexus Choroid plexus tumor Choroid plexus papilloma Choroid plexus carcinoma Multiple/unknown Oligoastrocytoma Gliomatosis cerebri Gliosarcoma Mature neuron Ganglioneuroma : Ganglioglioma Retinoblastoma Neurocytoma Dysembryoplastic neuroepithelial tumour Lhermitte–Duclos disease PNET Neuroblastoma Esthesioneuroblastoma Ganglioneuroblastoma Medulloblastoma Atypical teratoid rhabdoid tumor Primitive Medulloepithelioma Meninges Meningioma Hemangiopericytoma Hematopoietic Primary central nervous system lymphoma PNS : Nerve sheath tumor Cranial and paraspinal nerves Neurofibroma Neurofibromatosis Neurilemmoma / Schwannoma Acoustic neuroma Malignant peripheral nerve sheath tumor Other WHO classification of the tumors of the central nervous system Note: Not all brain tumors are of nervous tissue, and not all nervous tissue tumors are in the brain (see brain metastasis ). v t e Deficiencies of intracellular signaling peptides and proteins GTP-binding protein regulators GTPase-activating protein Neurofibromatosis type I Watson syndrome Tuberous sclerosis Guanine nucleotide exchange factor Marinesco–Sjögren syndrome Aarskog–Scott syndrome Juvenile primary lateral sclerosis X-Linked mental retardation 1 G protein Heterotrimeic cAMP / GNAS1 : Pseudopseudohypoparathyroidism Progressive osseous heteroplasia Pseudohypoparathyroidism Albright's hereditary osteodystrophy McCune–Albright syndrome CGL 2 Monomeric RAS: HRAS Costello syndrome KRAS Noonan syndrome 3 KRAS Cardiofaciocutaneous syndrome RAB: RAB7 Charcot–Marie–Tooth disease RAB23 Carpenter syndrome RAB27 Griscelli syndrome type 2 RHO: RAC2 Neutrophil immunodeficiency syndrome ARF : SAR1B Chylomicron retention disease ARL13B Joubert syndrome 8 ARL6 Bardet–Biedl syndrome 3 MAP kinase Cardiofaciocutaneous syndrome Other kinase / phosphatase Tyrosine kinase BTK X-linked agammaglobulinemia ZAP70 ZAP70 deficiency Serine/threonine kinase RPS6KA3 Coffin-Lowry syndrome CHEK2 Li-Fraumeni syndrome 2 IKBKG Incontinentia pigmenti STK11 Peutz–Jeghers syndrome DMPK Myotonic dystrophy 1 ATR Seckel syndrome 1 GRK1 Oguchi disease 2 WNK4 / WNK1 Pseudohypoaldosteronism 2 Tyrosine phosphatase PTEN Bannayan–Riley–Ruvalcaba syndrome Lhermitte–Duclos disease Cowden syndrome Proteus-like syndrome MTM1 X-linked myotubular myopathy PTPN11 Noonan syndrome 1 LEOPARD syndrome Metachondromatosis Signal transducing adaptor proteins EDARADD EDARADD Hypohidrotic ectodermal dysplasia SH3BP2 Cherubism LDB3 Zaspopathy Other NF2 Neurofibromatosis type II NOTCH3 CADASIL PRKAR1A Carney complex PRKAG2 Wolff–Parkinson–White syndrome PRKCSH PRKCSH Polycystic liver disease XIAP XIAP2 See also intracellular signaling peptides and proteins
    NF2, NF1, SMARCB1, LZTR1, EZR, ACTB, CDKN2A, BAP1, VEGFA, RAC1, YAP1, PAK1, TP53, NEFH, EPB41L3, ETV5, PTGS2, PIK3CA, PGR, MIR296, CD44, CXCR4, MSN, COX8A, MDM2, CTNNB1, MIB1, TCHP, DNMT1, IL17RA, TAZ, AMOT, MIR152, VHL, SAV1, AJUBA, TIMP3, SYK, CADM1, STAT3, SST, SRC, SMS, SMARCE1, IGLL5, SGK1, SRSF5, GOPC, SLC17A6, VTN, FBLIM1, CABIN1, WWC1, LATS2, SIRT2, MORC2, RASSF1, POSTN, PDLIM5, SEMA3F, DCAF1, MSC, HGS, SOCS2, SHANK3, EIF3C, TEAD2, RSS, AGO2, BIN2, BMS1P20, PRKAR1A, RDX, ELF4, CCN1, HTC2, HARS1, MTOR, FLT1, FASN, ESR1, ERBB2, EPO, EPHA1, ENG, EGFR, IL1B, EGF, ATN1, DNMT3A, CYP19A1, CCN2, CRYBB3, CRYBB2, CAPN5, BRCA1, BCR, BCL2, IGLV@, IL10, PXN, PEBP1, PTPRJ, PTGDS, MAP2K2, MAP2K1, AREG, PLG, PLAT, PIK3CG, PIK3CD, PIK3CB, SERPINE1, NHS, KDR, NEDD8, COX2, MTAP, MN1, MKI67, MEN1, MEFV, LRP6, LIMK2, LIMK1, LIF, MTCO2P12
    • Neurofibromatosis Type 2 Orphanet
      Genetic counseling NF2 is a dominantly inherited tumor predisposition syndrome. Management and treatment NF2 represents a difficult management problem with most patients facing substantial morbidity and reducedlife expectancy.
    • Neurofibromatosis 2 Gene_reviews
      Summary Clinical characteristics. Neurofibromatosis 2 (NF2) is characterized by bilateral vestibular schwannomas with associated symptoms of tinnitus, hearing loss, and balance dysfunction. The average age of onset is 18 to 24 years. Almost all affected individuals develop bilateral vestibular schwannomas by age 30 years. Affected individuals may also develop schwannomas of other cranial and peripheral nerves, meningiomas, ependymomas, and, very rarely, astrocytomas. Because NF2 is considered an adult-onset disease, it may be underrecognized in children, in whom skin tumors and ocular findings (retinal hamartoma, thickened optic nerves, cortical wedge cataracts, third cranial nerve palsy) may be the first manifestations. Mononeuropathy that occurs in childhood is an increasingly recognized finding; it frequently presents as a persistent facial palsy or hand/foot drop.
    • Neurofibromatosis Type 2 Gard
      Neurofibromatosis type 2 (NF2) is a disorder characterized by the growth of noncancerous tumors of the nervous system. Childhood symptoms include skin growths and eye findings. Almost all people with NF2 develop vestibular schwannomas affecting both ears by age 30. Other tumors of the central nervous system (the brain and spinal cord), skin and eye are also common. The signs and symptoms vary from person to person. The severity depends on the size, location, and number of tumors. NF2 is caused by changes (mutations) in the NF2 gene and is inherited in an autosomal dominant manner.
    • Neurofibromatosis, Type Ii Omim
      Description The central or type II form of neurofibromatosis (NF2) is an autosomal dominant multiple neoplasia syndrome characterized by tumors of the eighth cranial nerve (usually bilateral), meningiomas of the brain, and schwannomas of the dorsal roots of the spinal cord.
    • Neurofibromatosis Type 2 Medlineplus
      Neurofibromatosis type 2 is a disorder characterized by the growth of noncancerous tumors in the nervous system. The most common tumors associated with neurofibromatosis type 2 are called vestibular schwannomas or acoustic neuromas. These growths develop along the nerve that carries information from the inner ear to the brain (the auditory nerve). Tumors that occur on other nerves are also commonly found with this condition. The signs and symptoms of neurofibromatosis type 2 usually appear during adolescence or in a person's early twenties, although they can begin at any age.
  • Breast Cancer Medlineplus
    A significantly increased risk of breast cancer is also a feature of several rare genetic syndromes. These include Cowden syndrome, which is most often caused by mutations in the PTEN gene; hereditary diffuse gastric cancer, which results from mutations in the CDH1 gene; Li-Fraumeni syndrome, which is usually caused by mutations in the TP53 gene; and Peutz-Jeghers syndrome, which typically results from mutations in the STK11 gene. ... Although breast cancer is more common in women than in men, the mutated gene can be inherited from either the mother or the father. In the other syndromes discussed above, the gene mutations that increase cancer risk also have an autosomal dominant pattern of inheritance.
    BRCA2, BRCA1, ERBB2, HIF1A, PIK3CA, CHEK2
  • X-Linked Myotubular Myopathy Wikipedia
    External links [ edit ] GeneReview/NCBI/NIH/UW entry on X-Linked Myotubular Myopathy Classification D ICD - 10 : G71.2 OMIM : 310400 MeSH : C538647 External resources Orphanet : 596 v t e Diseases of muscle , neuromuscular junction , and neuromuscular disease Neuromuscular- junction disease autoimmune Myasthenia gravis Lambert–Eaton myasthenic syndrome Neuromyotonia Myopathy Muscular dystrophy ( DAPC ) AD Limb-girdle muscular dystrophy 1 Oculopharyngeal Facioscapulohumeral Myotonic Distal (most) AR Calpainopathy Limb-girdle muscular dystrophy 2 Congenital Fukuyama Ullrich Walker–Warburg XR dystrophin Becker's Duchenne Emery–Dreifuss Other structural collagen disease Bethlem myopathy PTP disease X-linked MTM adaptor protein disease BIN1-linked centronuclear myopathy cytoskeleton disease Nemaline myopathy Zaspopathy Channelopathy Myotonia Myotonia congenita Thomsen disease Neuromyotonia / Isaacs syndrome Paramyotonia congenita Periodic paralysis Hypokalemic Thyrotoxic Hyperkalemic Other Central core disease Mitochondrial myopathy MELAS MERRF KSS PEO General Inflammatory myopathy Congenital myopathy v t e X-linked disorders X-linked recessive Immune Chronic granulomatous disease (CYBB) Wiskott–Aldrich syndrome X-linked severe combined immunodeficiency X-linked agammaglobulinemia Hyper-IgM syndrome type 1 IPEX X-linked lymphoproliferative disease Properdin deficiency Hematologic Haemophilia A Haemophilia B X-linked sideroblastic anemia Endocrine Androgen insensitivity syndrome / Spinal and bulbar muscular atrophy KAL1 Kallmann syndrome X-linked adrenal hypoplasia congenita Metabolic Amino acid : Ornithine transcarbamylase deficiency Oculocerebrorenal syndrome Dyslipidemia : Adrenoleukodystrophy Carbohydrate metabolism : Glucose-6-phosphate dehydrogenase deficiency Pyruvate dehydrogenase deficiency Danon disease/glycogen storage disease Type IIb Lipid storage disorder : Fabry's disease Mucopolysaccharidosis : Hunter syndrome Purine–pyrimidine metabolism : Lesch–Nyhan syndrome Mineral : Menkes disease / Occipital horn syndrome Nervous system X-linked intellectual disability : Coffin–Lowry syndrome MASA syndrome Alpha-thalassemia mental retardation syndrome Siderius X-linked mental retardation syndrome Eye disorders: Color blindness (red and green, but not blue) Ocular albinism ( 1 ) Norrie disease Choroideremia Other: Charcot–Marie–Tooth disease (CMTX2-3) Pelizaeus–Merzbacher disease SMAX2 Skin and related tissue Dyskeratosis congenita Hypohidrotic ectodermal dysplasia (EDA) X-linked ichthyosis X-linked endothelial corneal dystrophy Neuromuscular Becker's muscular dystrophy / Duchenne Centronuclear myopathy (MTM1) Conradi–Hünermann syndrome Emery–Dreifuss muscular dystrophy 1 Urologic Alport syndrome Dent's disease X-linked nephrogenic diabetes insipidus Bone / tooth AMELX Amelogenesis imperfecta No primary system Barth syndrome McLeod syndrome Smith–Fineman–Myers syndrome Simpson–Golabi–Behmel syndrome Mohr–Tranebjærg syndrome Nasodigitoacoustic syndrome X-linked dominant X-linked hypophosphatemia Focal dermal hypoplasia Fragile X syndrome Aicardi syndrome Incontinentia pigmenti Rett syndrome CHILD syndrome Lujan–Fryns syndrome Orofaciodigital syndrome 1 Craniofrontonasal dysplasia v t e Deficiencies of intracellular signaling peptides and proteins GTP-binding protein regulators GTPase-activating protein Neurofibromatosis type I Watson syndrome Tuberous sclerosis Guanine nucleotide exchange factor Marinesco–Sjögren syndrome Aarskog–Scott syndrome Juvenile primary lateral sclerosis X-Linked mental retardation 1 G protein Heterotrimeic cAMP / GNAS1 : Pseudopseudohypoparathyroidism Progressive osseous heteroplasia Pseudohypoparathyroidism Albright's hereditary osteodystrophy McCune–Albright syndrome CGL 2 Monomeric RAS: HRAS Costello syndrome KRAS Noonan syndrome 3 KRAS Cardiofaciocutaneous syndrome RAB: RAB7 Charcot–Marie–Tooth disease RAB23 Carpenter syndrome RAB27 Griscelli syndrome type 2 RHO: RAC2 Neutrophil immunodeficiency syndrome ARF : SAR1B Chylomicron retention disease ARL13B Joubert syndrome 8 ARL6 Bardet–Biedl syndrome 3 MAP kinase Cardiofaciocutaneous syndrome Other kinase / phosphatase Tyrosine kinase BTK X-linked agammaglobulinemia ZAP70 ZAP70 deficiency Serine/threonine kinase RPS6KA3 Coffin-Lowry syndrome CHEK2 Li-Fraumeni syndrome 2 IKBKG Incontinentia pigmenti STK11 Peutz–Jeghers syndrome DMPK Myotonic dystrophy 1 ATR Seckel syndrome 1 GRK1 Oguchi disease 2 WNK4 / WNK1 Pseudohypoaldosteronism 2 Tyrosine phosphatase PTEN Bannayan–Riley–Ruvalcaba syndrome Lhermitte–Duclos disease Cowden syndrome Proteus-like syndrome MTM1 X-linked myotubular myopathy PTPN11 Noonan syndrome 1 LEOPARD syndrome Metachondromatosis Signal transducing adaptor proteins EDARADD EDARADD Hypohidrotic ectodermal dysplasia SH3BP2 Cherubism LDB3 Zaspopathy Other NF2 Neurofibromatosis type II NOTCH3 CADASIL PRKAR1A Carney complex PRKAG2 Wolff–Parkinson–White syndrome PRKCSH PRKCSH Polycystic liver disease XIAP XIAP2 See also intracellular signaling peptides and proteins
    MTM1, DNM2, BIN1, RYR1, ACTA1, ORAI1, MTMR14, SELENON, TPM3, TPM2, STIM1, CCDC78, MYH7, MTMR2, DES, CMTM1, MTMR1, PTPRU, ATP2B3, GABRA3, MTMR12, SLC25A3, MAMLD1, REG1A, VIM, IDS, MBNL1, NEFL, ACHE
    • X-Linked Myotubular Myopathy Gene_reviews
      ., cores) Central nuclei usually not increased Congenital myasthenic syndromes >25 genes AD AR Can present w/similar symptoms in early childhood, w/facial & extremity weakness & involvement of extraocular muscles Both conditions may respond to mestinon.
    • X-Linked Myotubular Myopathy Medlineplus
      X-linked myotubular myopathy is a condition that primarily affects muscles used for movement (skeletal muscles) and occurs almost exclusively in males. People with this condition have muscle weakness (myopathy) and decreased muscle tone (hypotonia) that are usually evident at birth. The muscle problems in X-linked myotubular myopathy impair the development of motor skills such as sitting, standing, and walking. Affected infants may also have difficulties with feeding due to muscle weakness. Individuals with this condition often do not have the muscle strength to breathe on their own and must be supported with a machine to help them breathe (mechanical ventilation).
    • X-Linked Centronuclear Myopathy Orphanet
      A rare X-linked congenital myopathy characterized by numerous centrally placed nuclei on muscle biopsy and that presents at birth with marked weakness, hypotonia and respiratory failure. Epidemiology The birth prevalence of X-linked centronuclear myopathy (XLMTM) is estimated at 1/50,000 males. Clinical description The disease is characterized by a severe phenotype in males presenting at birth with marked weakness, hypotonia and respiratory failure. Signs of antenatal onset are frequent and comprise reduced fetal movements and polyhydramnios. Thinning of the ribs is observed on chest radiographs of the newborn.
    • X-Linked Myotubular Myopathy Gard
      X-linked myotubular myopathy (XLMTM) is a type of centronuclear myopathy , which is a group of rare, inherited conditions that affect the muscles. XLMTM, specifically, occurs almost exclusively in males and is characterized by progressive muscle weakness (myopathy) and decreased muscle tone (hypotonia) that can range from mild to severe. The muscle problems impair the development of motor skills such as sitting, standing, and walking, and may disrupt primary functions such as breathing and feeding. XLMTM is caused by changes (mutations) in the MTM1 gene and is inherited in an X-linked recessive manner. Treatment is based on the signs and symptoms present in each person and may include physical and/or occupational therapy and assistive devices to help with mobility, eating and/or breathing.
    • Myopathy, Centronuclear, X-Linked Omim
      See myotubular myopathy with abnormal genital development (300219), a possible contiguous gene syndrome. Clinical Features Van Wijngaarden et al. (1969) described this disorder in 5 affected males in 4 sibships connected through females who in 2 instances showed partial manifestations on muscle biopsy. ... Comparison of this deletion with that carried by a male patient with a severe Hunter syndrome (309900) phenotype but no myotubular myopathy, in combination with linkage data on recombinant MTM1 families, led to a positional refinement of the MTM1 locus to a 600-kb region between DXS304 and DXS497. ... Although the authors considered the contiguous gene syndrome associated with abnormal genital development (300219), the patient only had cryptorchidism as an anomaly and showed expression of the F18 gene (MAMLD1; 300120), which is believed to be deleted in that disorder.
  • Fissured Tongue Wikipedia
    Associated conditions [ edit ] Fissured tongue is seen in Melkersson-Rosenthal syndrome (along with facial nerve paralysis and granulomatous cheilitis ). It is also seen in most patients with Down syndrome , in association with geographic tongue , in patients with oral manifestations of psoriasis , and in healthy individuals. Fissured tongue is also sometimes a feature of Cowden's syndrome . Cause [ edit ] The cause is unknown, but it may be partly a genetic trait. ... Frequency of Tongue Anomalies in Primary School Of Lahidjan. 3. 2003; 12 (45) :36-42 ] ^ a b Geriatric Nutrition: The Health Professional's Handbook, Ronni Chernoff, (Jones & Bartlett Learning, 2006), page 176 External links [ edit ] Classification D ICD - 10 : K14.5 ICD - 9-CM : 529.5 , 750.13 OMIM : 137400 MeSH : D014063 DiseasesDB : 32503 External resources eMedicine : derm/665 v t e Oral and maxillofacial pathology Lips Cheilitis Actinic Angular Plasma cell Cleft lip Congenital lip pit Eclabium Herpes labialis Macrocheilia Microcheilia Nasolabial cyst Sun poisoning Trumpeter's wart Tongue Ankyloglossia Black hairy tongue Caviar tongue Crenated tongue Cunnilingus tongue Fissured tongue Foliate papillitis Glossitis Geographic tongue Median rhomboid glossitis Transient lingual papillitis Glossoptosis Hypoglossia Lingual thyroid Macroglossia Microglossia Rhabdomyoma Palate Bednar's aphthae Cleft palate High-arched palate Palatal cysts of the newborn Inflammatory papillary hyperplasia Stomatitis nicotina Torus palatinus Oral mucosa – Lining of mouth Amalgam tattoo Angina bullosa haemorrhagica Behçet's disease Bohn's nodules Burning mouth syndrome Candidiasis Condyloma acuminatum Darier's disease Epulis fissuratum Erythema multiforme Erythroplakia Fibroma Giant-cell Focal epithelial hyperplasia Fordyce spots Hairy leukoplakia Hand, foot and mouth disease Hereditary benign intraepithelial dyskeratosis Herpangina Herpes zoster Intraoral dental sinus Leukoedema Leukoplakia Lichen planus Linea alba Lupus erythematosus Melanocytic nevus Melanocytic oral lesion Molluscum contagiosum Morsicatio buccarum Oral cancer Benign: Squamous cell papilloma Keratoacanthoma Malignant: Adenosquamous carcinoma Basaloid squamous carcinoma Mucosal melanoma Spindle cell carcinoma Squamous cell carcinoma Verrucous carcinoma Oral florid papillomatosis Oral melanosis Smoker's melanosis Pemphigoid Benign mucous membrane Pemphigus Plasmoacanthoma Stomatitis Aphthous Denture-related Herpetic Smokeless tobacco keratosis Submucous fibrosis Ulceration Riga–Fede disease Verruca vulgaris Verruciform xanthoma White sponge nevus Teeth ( pulp , dentin , enamel ) Amelogenesis imperfecta Ankylosis Anodontia Caries Early childhood caries Concrescence Failure of eruption of teeth Dens evaginatus Talon cusp Dentin dysplasia Dentin hypersensitivity Dentinogenesis imperfecta Dilaceration Discoloration Ectopic enamel Enamel hypocalcification Enamel hypoplasia Turner's hypoplasia Enamel pearl Fluorosis Fusion Gemination Hyperdontia Hypodontia Maxillary lateral incisor agenesis Impaction Wisdom tooth impaction Macrodontia Meth mouth Microdontia Odontogenic tumors Keratocystic odontogenic tumour Odontoma Dens in dente Open contact Premature eruption Neonatal teeth Pulp calcification Pulp stone Pulp canal obliteration Pulp necrosis Pulp polyp Pulpitis Regional odontodysplasia Resorption Shovel-shaped incisors Supernumerary root Taurodontism Trauma Avulsion Cracked tooth syndrome Vertical root fracture Occlusal Tooth loss Edentulism Tooth wear Abrasion Abfraction Acid erosion Attrition Periodontium ( gingiva , periodontal ligament , cementum , alveolus ) – Gums and tooth-supporting structures Cementicle Cementoblastoma Gigantiform Cementoma Eruption cyst Epulis Pyogenic granuloma Congenital epulis Gingival enlargement Gingival cyst of the adult Gingival cyst of the newborn Gingivitis Desquamative Granulomatous Plasma cell Hereditary gingival fibromatosis Hypercementosis Hypocementosis Linear gingival erythema Necrotizing periodontal diseases Acute necrotizing ulcerative gingivitis Pericoronitis Peri-implantitis Periodontal abscess Periodontal trauma Periodontitis Aggressive As a manifestation of systemic disease Chronic Perio-endo lesion Teething Periapical, mandibular and maxillary hard tissues – Bones of jaws Agnathia Alveolar osteitis Buccal exostosis Cherubism Idiopathic osteosclerosis Mandibular fracture Microgenia Micrognathia Intraosseous cysts Odontogenic : periapical Dentigerous Buccal bifurcation Lateral periodontal Globulomaxillary Calcifying odontogenic Glandular odontogenic Non-odontogenic: Nasopalatine duct Median mandibular Median palatal Traumatic bone Osteoma Osteomyelitis Osteonecrosis Bisphosphonate-associated Neuralgia-inducing cavitational osteonecrosis Osteoradionecrosis Osteoporotic bone marrow defect Paget's disease of bone Periapical abscess Phoenix abscess Periapical periodontitis Stafne defect Torus mandibularis Temporomandibular joints , muscles of mastication and malocclusions – Jaw joints, chewing muscles and bite abnormalities Bruxism Condylar resorption Mandibular dislocation Malocclusion Crossbite Open bite Overbite Overeruption Overjet Prognathia Retrognathia Scissor bite Maxillary hypoplasia Temporomandibular joint dysfunction Salivary glands Benign lymphoepithelial lesion Ectopic salivary gland tissue Frey's syndrome HIV salivary gland disease Necrotizing sialometaplasia Mucocele Ranula Pneumoparotitis Salivary duct stricture Salivary gland aplasia Salivary gland atresia Salivary gland diverticulum Salivary gland fistula Salivary gland hyperplasia Salivary gland hypoplasia Salivary gland neoplasms Benign: Basal cell adenoma Canalicular adenoma Ductal papilloma Monomorphic adenoma Myoepithelioma Oncocytoma Papillary cystadenoma lymphomatosum Pleomorphic adenoma Sebaceous adenoma Malignant: Acinic cell carcinoma Adenocarcinoma Adenoid cystic carcinoma Carcinoma ex pleomorphic adenoma Lymphoma Mucoepidermoid carcinoma Sclerosing polycystic adenosis Sialadenitis Parotitis Chronic sclerosing sialadenitis Sialectasis Sialocele Sialodochitis Sialosis Sialolithiasis Sjögren's syndrome Orofacial soft tissues – Soft tissues around the mouth Actinomycosis Angioedema Basal cell carcinoma Cutaneous sinus of dental origin Cystic hygroma Gnathophyma Ludwig's angina Macrostomia Melkersson–Rosenthal syndrome Microstomia Noma Oral Crohn's disease Orofacial granulomatosis Perioral dermatitis Pyostomatitis vegetans Other Eagle syndrome Hemifacial hypertrophy Facial hemiatrophy Oral manifestations of systemic disease
    KRT6A, AKT1, CC2D2A, WDPCP, TMEM216, MKS1, CEP55, SLC39A4, RPGRIP1, TMEM231, RAB3GAP2, CSPP1, TCTN2, CEP290, B9D2, TMEM107, TMEM67, B9D1, RPGRIP1L, GJB2, SDHD, PIK3CA, PKP1, PTEN, SDHB, RAB3GAP1, SDHC, KDM5C, ECEL1, ABCC9, SEC23B, GJB6, KLLN, KRT16, HLA-DRB1, HLA-C
    • Geographic And Fissured Tongue Omim
      Clinical Features Turpin and Caratzali (1936) concluded that the same gene is responsible for both geographic tongue and fissured tongue. Dawson and Pielou (1967) observed 18 persons with geographic tongue, some of whom also had fissured tongue, in 3 generations with probable autosomal dominant pattern. Under the designation 'scrotal tongue,' Tobias (1945) reported 2 families, one with 2 generations and the other with 4 generations affected. Geographic tongue was an associated feature in the proband of 1 family. Seiler (1936) assembled the most extensive pedigree data supporting autosomal dominant inheritance.
  • Oguchi Disease Wikipedia
    External links [ edit ] Oguchi disease at NIH 's Office of Rare Diseases Classification D ICD - 9-CM : 368.61 OMIM : 258100 MeSH : C537743 External resources Orphanet : 75382 v t e Diseases of the human eye Adnexa Eyelid Inflammation Stye Chalazion Blepharitis Entropion Ectropion Lagophthalmos Blepharochalasis Ptosis Blepharophimosis Xanthelasma Ankyloblepharon Eyelash Trichiasis Madarosis Lacrimal apparatus Dacryoadenitis Epiphora Dacryocystitis Xerophthalmia Orbit Exophthalmos Enophthalmos Orbital cellulitis Orbital lymphoma Periorbital cellulitis Conjunctiva Conjunctivitis allergic Pterygium Pseudopterygium Pinguecula Subconjunctival hemorrhage Globe Fibrous tunic Sclera Scleritis Episcleritis Cornea Keratitis herpetic acanthamoebic fungal Exposure Photokeratitis Corneal ulcer Thygeson's superficial punctate keratopathy Corneal dystrophy Fuchs' Meesmann Corneal ectasia Keratoconus Pellucid marginal degeneration Keratoglobus Terrien's marginal degeneration Post-LASIK ectasia Keratoconjunctivitis sicca Corneal opacity Corneal neovascularization Kayser–Fleischer ring Haab's striae Arcus senilis Band keratopathy Vascular tunic Iris Ciliary body Uveitis Intermediate uveitis Hyphema Rubeosis iridis Persistent pupillary membrane Iridodialysis Synechia Choroid Choroideremia Choroiditis Chorioretinitis Lens Cataract Congenital cataract Childhood cataract Aphakia Ectopia lentis Retina Retinitis Chorioretinitis Cytomegalovirus retinitis Retinal detachment Retinoschisis Ocular ischemic syndrome / Central retinal vein occlusion Central retinal artery occlusion Branch retinal artery occlusion Retinopathy diabetic hypertensive Purtscher's of prematurity Bietti's crystalline dystrophy Coats' disease Sickle cell Macular degeneration Retinitis pigmentosa Retinal haemorrhage Central serous retinopathy Macular edema Epiretinal membrane (Macular pucker) Vitelliform macular dystrophy Leber's congenital amaurosis Birdshot chorioretinopathy Other Glaucoma / Ocular hypertension / Primary juvenile glaucoma Floater Leber's hereditary optic neuropathy Red eye Globe rupture Keratomycosis Phthisis bulbi Persistent fetal vasculature / Persistent hyperplastic primary vitreous Persistent tunica vasculosa lentis Familial exudative vitreoretinopathy Pathways Optic nerve Optic disc Optic neuritis optic papillitis Papilledema Foster Kennedy syndrome Optic atrophy Optic disc drusen Optic neuropathy Ischemic anterior (AION) posterior (PION) Kjer's Leber's hereditary Toxic and nutritional Strabismus Extraocular muscles Binocular vision Accommodation Paralytic strabismus Ophthalmoparesis Chronic progressive external ophthalmoplegia Kearns–Sayre syndrome palsies Oculomotor (III) Fourth-nerve (IV) Sixth-nerve (VI) Other strabismus Esotropia / Exotropia Hypertropia Heterophoria Esophoria Exophoria Cyclotropia Brown's syndrome Duane syndrome Other binocular Conjugate gaze palsy Convergence insufficiency Internuclear ophthalmoplegia One and a half syndrome Refraction Refractive error Hyperopia Myopia Astigmatism Anisometropia / Aniseikonia Presbyopia Vision disorders Blindness Amblyopia Leber's congenital amaurosis Diplopia Scotoma Color blindness Achromatopsia Dichromacy Monochromacy Nyctalopia Oguchi disease Blindness / Vision loss / Visual impairment Anopsia Hemianopsia binasal bitemporal homonymous Quadrantanopia subjective Asthenopia Hemeralopia Photophobia Scintillating scotoma Pupil Anisocoria Argyll Robertson pupil Marcus Gunn pupil Adie syndrome Miosis Mydriasis Cycloplegia Parinaud's syndrome Other Nystagmus Childhood blindness Infections Trachoma Onchocerciasis v t e Cell membrane protein disorders (other than Cell surface receptor , enzymes , and cytoskeleton ) Arrestin Oguchi disease 1 Myelin Pelizaeus–Merzbacher disease Dejerine–Sottas disease Charcot–Marie–Tooth disease 1B, 2J Pulmonary surfactant Surfactant metabolism dysfunction 1, 2 Cell adhesion molecule IgSF CAM : OFC7 Cadherin : DSG1 Striate palmoplantar keratoderma 1 DSG2 Arrhythmogenic right ventricular dysplasia 10 DSG4 LAH1 DSC2 Arrhythmogenic right ventricular dysplasia 11 Integrin : cell surface receptor deficiencies Tetraspanin TSPAN7 X-Linked mental retardation 58 TSPAN12 Familial exudative vitreoretinopathy 5 Other KIND1 Kindler syndrome HFE HFE hereditary haemochromatosis DYSF Distal muscular dystrophy Limb-girdle muscular dystrophy 2B See also other cell membrane proteins v t e Deficiencies of intracellular signaling peptides and proteins GTP-binding protein regulators GTPase-activating protein Neurofibromatosis type I Watson syndrome Tuberous sclerosis Guanine nucleotide exchange factor Marinesco–Sjögren syndrome Aarskog–Scott syndrome Juvenile primary lateral sclerosis X-Linked mental retardation 1 G protein Heterotrimeic cAMP / GNAS1 : Pseudopseudohypoparathyroidism Progressive osseous heteroplasia Pseudohypoparathyroidism Albright's hereditary osteodystrophy McCune–Albright syndrome CGL 2 Monomeric RAS: HRAS Costello syndrome KRAS Noonan syndrome 3 KRAS Cardiofaciocutaneous syndrome RAB: RAB7 Charcot–Marie–Tooth disease RAB23 Carpenter syndrome RAB27 Griscelli syndrome type 2 RHO: RAC2 Neutrophil immunodeficiency syndrome ARF : SAR1B Chylomicron retention disease ARL13B Joubert syndrome 8 ARL6 Bardet–Biedl syndrome 3 MAP kinase Cardiofaciocutaneous syndrome Other kinase / phosphatase Tyrosine kinase BTK X-linked agammaglobulinemia ZAP70 ZAP70 deficiency Serine/threonine kinase RPS6KA3 Coffin-Lowry syndrome CHEK2 Li-Fraumeni syndrome 2 IKBKG Incontinentia pigmenti STK11 Peutz–Jeghers syndrome DMPK Myotonic dystrophy 1 ATR Seckel syndrome 1 GRK1 Oguchi disease 2 WNK4 / WNK1 Pseudohypoaldosteronism 2 Tyrosine phosphatase PTEN Bannayan–Riley–Ruvalcaba syndrome Lhermitte–Duclos disease Cowden syndrome Proteus-like syndrome MTM1 X-linked myotubular myopathy PTPN11 Noonan syndrome 1 LEOPARD syndrome Metachondromatosis Signal transducing adaptor proteins EDARADD EDARADD Hypohidrotic ectodermal dysplasia SH3BP2 Cherubism LDB3 Zaspopathy Other NF2 Neurofibromatosis type II NOTCH3 CADASIL PRKAR1A Carney complex PRKAG2 Wolff–Parkinson–White syndrome PRKCSH PRKCSH Polycystic liver disease XIAP XIAP2 See also intracellular signaling peptides and proteins
    SAG, GRK1, CACNA1F, RHO, GRK7, GUCY2D, RDH5, CERKL
    • Oguchi Disease 1 Omim
      A number sign (#) is used with this entry because of evidence that Oguchi disease-1 (CSNBO1) is caused by homozygous or compound heterozygous mutation in the arrestin gene (SAG; 181031) on chromosome 2q37. Description Oguchi disease is a rare autosomal recessive form of congenital stationary night blindness in which all other visual functions, including visual acuity, visual field, and color vision, are usually normal. A typical feature of the disease is a golden or gray-white discoloration of the fundus that disappears in the dark-adapted state and reappears shortly after the onset of light (Mizuo phenomenon, or Mizuo-Nakamura phenomenon). The course of dark adaptation of rod photoreceptors is extremely retarded, whereas that of cones appears to proceed normally (summary by Fuchs et al., 1995). Genetic Heterogeneity of Oguchi Disease Oguchi disease-2 (CSNBO2) is caused by mutation in the rhodopsin kinase gene (GRK1; 180381) on chromosome 13q34.
    • Oguchi Disease Orphanet
      Oguchi disease is an autosomal recessive retinal disorder characterized by congenital stationary night blindness (see this term) and the Mizuo-Nakamura phenomenon. Epidemiology Oguchi disease is a very rare condition with approximately 50 cases described in the literature to date. It was originally discovered in Japan where the prevalence is the highest but has been found occasionally in European, American, Pakistani and Indian patients. Clinical description The disease is characterized by congenital stationary night blindness and the Mizuo-Nakamura phenomenon which is a unique morphological and functional abnormality of the retina that presents with a typical golden-yellow or silver-gray discoloration of the fundus in the presence of light that disappears after dark-adaptation and appears again after the onset of light. Patients have non progressive night blindness since young childhood with normal day vision, but they often claim improvement of light sensitivities when they remain a long time in a dark environment.
    • Oguchi Disease 2 Omim
      A number sign (#) is used with this entry because of evidence that Oguchi disease-2 (CSNBO2) can be caused by homozygous mutation in the GRK1 gene (180381) on chromosome 13q34. Description Oguchi disease is a rare autosomal recessive form of congenital stationary night blindness in which all other visual functions, including visual acuity, visual field, and color vision, are usually normal. A typical feature of the disease is a golden or gray-white discoloration of the fundus that disappears in the dark-adapted state and reappears shortly after the onset of light (Mizuo phenomenon). The course of dark adaptation of rod photoreceptors is extremely retarded, whereas that of cones appears to proceed normally (summary by Fuchs et al., 1995). For a general description and a discussion of genetic heterogeneity of Oguchi disease, see CSNBO1 (258100).
  • Pseudopseudohypoparathyroidism Wikipedia
    "Pseudohypoparathyroidism: one gene, several syndromes". Journal of Endocrinological Investigation . 40 (4): 347–356. doi : 10.1007/s40618-016-0588-4 . ... Sadaf Farooqi; Stephen O'Rahilly (12 September 2008). The genetics of obesity syndromes . Oxford University Press US. pp. 91–. ... External links [ edit ] Classification D ICD - 9-CM : 275.49 OMIM : 612463 MeSH : D011556 DiseasesDB : 29783 Look up pseudopseudohypoparathyroidism in Wiktionary, the free dictionary. v t e Parathyroid disease Hypoparathyroidism Pseudohypoparathyroidism Pseudopseudohypoparathyroidism Hyperparathyroidism Primary Secondary Tertiary Osteitis fibrosa cystica Other Parathyroiditis v t e Disorders due to genomic imprinting Chromosome 15 Angelman syndrome ♀ / Prader-Willi syndrome ♂ Chromosome 11 Beckwith–Wiedemann syndrome ♀ / Silver–Russell syndrome ♂ Myoclonic dystonia Chromosome 20 Pseudohypoparathyroidism ♀ / Pseudopseudohypoparathyroidism ♂ Chromosome 6 Transient neonatal diabetes mellitus v t e Deficiencies of intracellular signaling peptides and proteins GTP-binding protein regulators GTPase-activating protein Neurofibromatosis type I Watson syndrome Tuberous sclerosis Guanine nucleotide exchange factor Marinesco–Sjögren syndrome Aarskog–Scott syndrome Juvenile primary lateral sclerosis X-Linked mental retardation 1 G protein Heterotrimeic cAMP / GNAS1 : Pseudopseudohypoparathyroidism Progressive osseous heteroplasia Pseudohypoparathyroidism Albright's hereditary osteodystrophy McCune–Albright syndrome CGL 2 Monomeric RAS: HRAS Costello syndrome KRAS Noonan syndrome 3 KRAS Cardiofaciocutaneous syndrome RAB: RAB7 Charcot–Marie–Tooth disease RAB23 Carpenter syndrome RAB27 Griscelli syndrome type 2 RHO: RAC2 Neutrophil immunodeficiency syndrome ARF : SAR1B Chylomicron retention disease ARL13B Joubert syndrome 8 ARL6 Bardet–Biedl syndrome 3 MAP kinase Cardiofaciocutaneous syndrome Other kinase / phosphatase Tyrosine kinase BTK X-linked agammaglobulinemia ZAP70 ZAP70 deficiency Serine/threonine kinase RPS6KA3 Coffin-Lowry syndrome CHEK2 Li-Fraumeni syndrome 2 IKBKG Incontinentia pigmenti STK11 Peutz–Jeghers syndrome DMPK Myotonic dystrophy 1 ATR Seckel syndrome 1 GRK1 Oguchi disease 2 WNK4 / WNK1 Pseudohypoaldosteronism 2 Tyrosine phosphatase PTEN Bannayan–Riley–Ruvalcaba syndrome Lhermitte–Duclos disease Cowden syndrome Proteus-like syndrome MTM1 X-linked myotubular myopathy PTPN11 Noonan syndrome 1 LEOPARD syndrome Metachondromatosis Signal transducing adaptor proteins EDARADD EDARADD Hypohidrotic ectodermal dysplasia SH3BP2 Cherubism LDB3 Zaspopathy Other NF2 Neurofibromatosis type II NOTCH3 CADASIL PRKAR1A Carney complex PRKAG2 Wolff–Parkinson–White syndrome PRKCSH PRKCSH Polycystic liver disease XIAP XIAP2 See also intracellular signaling peptides and proteins
    GNAS, PTH, COASY, APRT, ASAH1, MFAP1, SOX3, PHPT1, CALCA, GH1, GHRH, STK24, HCAR3, STK25
    • Pseudopseudohypoparathyroidism Gard
      Pseudopseudohypoparathyroidism (PPHP) is an inherited condition that causes short stature, round face, and short hand bones. PPHP causes joints and other soft tissues in the body to harden. It also affects how bones are formed. As a result, PPHP can cause bone, joint, and nerve damage, and this damage can cause lasting pain. Some people with PPHP (10%) also have learning disability. PHPP is caused by mutations in the GNAS gene and is inherited in an autosomal dominant fashion. This condition is usually inherited from the father ( genomic imprinting ).
    • Pseudopseudohypoparathyroidism Orphanet
      Differential diagnosis The differential diagnosis includes PHP 1a, PHP 1c and 2q37 microdeletion syndrome (see these terms). Antenatal diagnosis Antenatal diagnosis is possible when a disease causing mutation in the family is known.
    • Pseudopseudohypoparathyroidism Omim
      A number sign (#) is used with this entry because pseudopseudohypoparathyroidism (PPHP) is caused by a mutation resulting in loss of function of the Gs-alpha isoform of the GNAS gene (139320) on the paternal allele. This results in expression of the Gs-alpha protein only from the maternal allele. See also pseudohypoparathyroidism type Ia (PHP1A; 103580), which is caused by a mutation resulting in loss of function of the Gs-alpha isoform of the GNAS gene on the maternal allele and resultant expression of the Gs-alpha protein only from the paternal allele. Description Patients with pseudopseudohypoparathyroidism do not show resistance to parathyroid hormone (PTH; 168450) or other hormones, as is the case with PHP1A (103580), but do manifest the constellation of clinical features referred to as Albright hereditary osteodystrophy (AHO), which includes short stature, obesity, round facies, subcutaneous ossifications, brachydactyly, and other skeletal anomalies. Some patients have mental retardation (Kinard et al., 1979; Fitch, 1982; Mantovani and Spada, 2006).
  • Costello Syndrome Wikipedia
    Costello syndrome Other names Faciocutaneoskeletal syndrome Costello syndrome is inherited in an autosomal dominant manner. Specialty Medical genetics Costello syndrome , also called faciocutaneoskeletal syndrome or FCS syndrome , is a rare genetic disorder that affects many parts of the body. ... After his presentation, members of the Costello Syndrome Family Network discussed the possibility of FTIs helping children with Costello syndrome. ... When this was reported in mainstream news, the Costello Syndrome Professional Advisory Board was asked about its use in Costello Syndrome. ... S2CID 22119631 . ^ Lisa Schoyer, 2007 Costello syndrome medical symposium. Some text in this article was originally taken from http://ghr.nlm.nih.gov/condition=costellosyndrome , a public domain source External links [ edit ] Classification D OMIM : 218040 MeSH : D056685 DiseasesDB : 32846 External resources Orphanet : 2143 GeneReviews: Costello Syndrome GeneReviews: Daisy's battle with Costello Syndrome v t e Deficiencies of intracellular signaling peptides and proteins GTP-binding protein regulators GTPase-activating protein Neurofibromatosis type I Watson syndrome Tuberous sclerosis Guanine nucleotide exchange factor Marinesco–Sjögren syndrome Aarskog–Scott syndrome Juvenile primary lateral sclerosis X-Linked mental retardation 1 G protein Heterotrimeic cAMP / GNAS1 : Pseudopseudohypoparathyroidism Progressive osseous heteroplasia Pseudohypoparathyroidism Albright's hereditary osteodystrophy McCune–Albright syndrome CGL 2 Monomeric RAS: HRAS Costello syndrome KRAS Noonan syndrome 3 KRAS Cardiofaciocutaneous syndrome RAB: RAB7 Charcot–Marie–Tooth disease RAB23 Carpenter syndrome RAB27 Griscelli syndrome type 2 RHO: RAC2 Neutrophil immunodeficiency syndrome ARF : SAR1B Chylomicron retention disease ARL13B Joubert syndrome 8 ARL6 Bardet–Biedl syndrome 3 MAP kinase Cardiofaciocutaneous syndrome Other kinase / phosphatase Tyrosine kinase BTK X-linked agammaglobulinemia ZAP70 ZAP70 deficiency Serine/threonine kinase RPS6KA3 Coffin-Lowry syndrome CHEK2 Li-Fraumeni syndrome 2 IKBKG Incontinentia pigmenti STK11 Peutz–Jeghers syndrome DMPK Myotonic dystrophy 1 ATR Seckel syndrome 1 GRK1 Oguchi disease 2 WNK4 / WNK1 Pseudohypoaldosteronism 2 Tyrosine phosphatase PTEN Bannayan–Riley–Ruvalcaba syndrome Lhermitte–Duclos disease Cowden syndrome Proteus-like syndrome MTM1 X-linked myotubular myopathy PTPN11 Noonan syndrome 1 LEOPARD syndrome Metachondromatosis Signal transducing adaptor proteins EDARADD EDARADD Hypohidrotic ectodermal dysplasia SH3BP2 Cherubism LDB3 Zaspopathy Other NF2 Neurofibromatosis type II NOTCH3 CADASIL PRKAR1A Carney complex PRKAG2 Wolff–Parkinson–White syndrome PRKCSH PRKCSH Polycystic liver disease XIAP XIAP2 See also intracellular signaling peptides and proteins
    HRAS
  • Aarskog–scott Syndrome Wikipedia
    Aarskog–Scott syndrome / Aarskog Syndrome Other names Faciodigitogenital syndrome (FGDY), faciogenital dysplasia, Aarskog disease, Scott Aarskog syndrome [1] Specialty Medical genetics Symptoms Broad hands and feet, wide set eyes, low set ears, drooping lower lip [1] Causes Genetic ( X-linked recessive ) [1] Deaths 2018, two deaths one patient aged 66 years, another aged 62 also diagnosed with Non-Hodgkin lymphoma 2019 one death aged 54. ... The cause of Aarskog-Scott syndrome in other affected individuals is unknown. [3] Pathophysiology [ edit ] The Aarskog–Scott syndrome is due to mutation in the FGD1 gene. ... Scott, Jr., an American medical geneticist who independently described the syndrome in 1971. [9] References [ edit ] ^ a b c "Aarskog syndrome" . rarediseases.info.nih.gov . ... External links [ edit ] Aarskog–Scott syndrome , detailed up-to-date information in OMIM (Online Mendelian Inheritance in Man) Aarskog's syndrome at Who Named It? The Aarskog Foundation Classification D ICD - 10 : Q87.1 ICD - 9-CM : 759.89 OMIM : 100050 MeSH : C535331 DiseasesDB : 29329 External resources MedlinePlus : 001654 Orphanet : 915 v t e Congenital abnormality syndromes Craniofacial Acrocephalosyndactylia Apert syndrome Carpenter syndrome Pfeiffer syndrome Saethre–Chotzen syndrome Sakati–Nyhan–Tisdale syndrome Bonnet–Dechaume–Blanc syndrome Other Baller–Gerold syndrome Cyclopia Goldenhar syndrome Möbius syndrome Short stature 1q21.1 deletion syndrome Aarskog–Scott syndrome Cockayne syndrome Cornelia de Lange syndrome Dubowitz syndrome Noonan syndrome Robinow syndrome Silver–Russell syndrome Seckel syndrome Smith–Lemli–Opitz syndrome Snyder–Robinson syndrome Turner syndrome Limbs Adducted thumb syndrome Holt–Oram syndrome Klippel–Trénaunay–Weber syndrome Nail–patella syndrome Rubinstein–Taybi syndrome Gastrulation / mesoderm : Caudal regression syndrome Ectromelia Sirenomelia VACTERL association Overgrowth syndromes Beckwith–Wiedemann syndrome Proteus syndrome Perlman syndrome Sotos syndrome Weaver syndrome Klippel–Trénaunay–Weber syndrome Benign symmetric lipomatosis Bannayan–Riley–Ruvalcaba syndrome Neurofibromatosis type I Laurence–Moon–Bardet–Biedl Bardet–Biedl syndrome Laurence–Moon syndrome Combined/other, known locus 2 ( Feingold syndrome ) 3 ( Zimmermann–Laband syndrome ) 4 / 13 ( Fraser syndrome ) 8 ( Branchio-oto-renal syndrome , CHARGE syndrome ) 12 ( Keutel syndrome , Timothy syndrome ) 15 ( Marfan syndrome ) 19 ( Donohue syndrome ) Multiple Fryns syndrome v t e Deficiencies of intracellular signaling peptides and proteins GTP-binding protein regulators GTPase-activating protein Neurofibromatosis type I Watson syndrome Tuberous sclerosis Guanine nucleotide exchange factor Marinesco–Sjögren syndrome Aarskog–Scott syndrome Juvenile primary lateral sclerosis X-Linked mental retardation 1 G protein Heterotrimeic cAMP / GNAS1 : Pseudopseudohypoparathyroidism Progressive osseous heteroplasia Pseudohypoparathyroidism Albright's hereditary osteodystrophy McCune–Albright syndrome CGL 2 Monomeric RAS: HRAS Costello syndrome KRAS Noonan syndrome 3 KRAS Cardiofaciocutaneous syndrome RAB: RAB7 Charcot–Marie–Tooth disease RAB23 Carpenter syndrome RAB27 Griscelli syndrome type 2 RHO: RAC2 Neutrophil immunodeficiency syndrome ARF : SAR1B Chylomicron retention disease ARL13B Joubert syndrome 8 ARL6 Bardet–Biedl syndrome 3 MAP kinase Cardiofaciocutaneous syndrome Other kinase / phosphatase Tyrosine kinase BTK X-linked agammaglobulinemia ZAP70 ZAP70 deficiency Serine/threonine kinase RPS6KA3 Coffin-Lowry syndrome CHEK2 Li-Fraumeni syndrome 2 IKBKG Incontinentia pigmenti STK11 Peutz–Jeghers syndrome DMPK Myotonic dystrophy 1 ATR Seckel syndrome 1 GRK1 Oguchi disease 2 WNK4 / WNK1 Pseudohypoaldosteronism 2 Tyrosine phosphatase PTEN Bannayan–Riley–Ruvalcaba syndrome Lhermitte–Duclos disease Cowden syndrome Proteus-like syndrome MTM1 X-linked myotubular myopathy PTPN11 Noonan syndrome 1 LEOPARD syndrome Metachondromatosis Signal transducing adaptor proteins EDARADD EDARADD Hypohidrotic ectodermal dysplasia SH3BP2 Cherubism LDB3 Zaspopathy Other NF2 Neurofibromatosis type II NOTCH3 CADASIL PRKAR1A Carney complex PRKAG2 Wolff–Parkinson–White syndrome PRKCSH PRKCSH Polycystic liver disease XIAP XIAP2 See also intracellular signaling peptides and proteins
    FGD1, SOS1, RIT1, LZTR1, RAF1, ATR, CENPJ, CEP63, PTPN11, KRAS, MC2R, POMC, TSR2, MRAP, NNT, STAR, TXNRD2, RASGRF1, SLC2A4RG, ARHGEF2, PLEK, MCM4, GLI3, CYP11A1, FGD5, SGPL1, SMOC1, FGD3, TXNRD3, ACTB, AAAS, TRGC1, TRG, PGK1P1, PGAM2, MC1R, GH1, DECR1, CDKN1C, CDC42, BCL2, TARP
    • Aarskog-Scott Syndrome Omim
      Aarskog-Scott syndrome with attention deficit-hyperactivity disorder and a form of syndromic X-linked mental retardation (MRXS16) are also caused by mutation in the FGD1 gene. ... A 9-year-old brother showed full-blown Aarskog syndrome. The proband, her sister, and her mother showed signs interpreted as features of Aarskog syndrome. Friedman (1985) described the distinctive umbilical changes of Aarskog syndrome, Rieger syndrome (180500), and Robinow syndrome (180700). ... Fernandez et al. (1994) suggested that cardiac evaluation is indicated for all children with Aarskog syndrome. Fryns (1992) concluded that the incidence of mental handicap in Aarskog syndrome may be as high as 30%. ... They concluded that Aarskog syndrome is not associated with mental handicap.
    • Aarskog-Scott Syndrome Orphanet
      Differential diagnosis When molecular diagnosis is not conclusive, all possible options for differential diagnosis should still be considered, including Noonan syndrome, SHORT syndrome, pseudohypoparathyroidism and Robinow syndrome (see these terms).
    • Aarskog Syndrome Gard
      Aarskog syndrome is an inherited disease that affects a person's height, muscles, skeleton, genitals, and appearance of the face. ... About 20 percent of people with Aarskog-Scott syndrome have mutations in the FGD1 gene.
    • Aarskog Syndrome, Autosomal Dominant Omim
      Description Aarskog syndrome is characterized by short stature and facial, limb, and genital anomalies. ... Clinical Features Grier et al. (1983) reported father and 2 sons with typical Aarskog syndrome, including short stature, hypertelorism, and shawl scrotum. ... Inheritance Grier et al. (1983) tabulated the findings in 82 previously reported cases of Aarskog syndrome and noted that X-linked recessive inheritance was repeatedly suggested. ... Van de Vooren et al. (1983) studied a large family in which Aarskog syndrome was segregating with variable expression in 3 generations and with male-to-male transmission. Because 3 daughters of affected males had no features of Aarskog syndrome and 2 sons of an affected male had several features of the syndrome, van de Vooren et al. (1983) suggested sex-influenced autosomal dominant inheritance.
  • Sturge–weber Syndrome Wikipedia
    Sturge–Weber syndrome Other names Sturge–Weber–Krabbe disease CT scan of Sturge-Weber syndrome Specialty Medical genetics Sturge–Weber syndrome , sometimes referred to as encephalotrigeminal angiomatosis , is a rare congenital neurological and skin disorder. ... More research is needed on this type of Sturge–Weber syndrome. Type 3 has leptomeningeal angioma involvement exclusively. ... "Sturge–Weber Syndrome and Port-Wine Stains Caused by Somatic Mutation in" . ... Further reading [ edit ] Wikimedia Commons has media related to Sturge–Weber syndrome . Greenwood M, Meechan JG (July 2003). ... Fig. 2 A patient with Sturge Weber Syndrome External links [ edit ] Classification D ICD - 10 : Q85.8 ICD - 9-CM : 759.6 OMIM : 185300 MeSH : D013341 DiseasesDB : 12572 External resources MedlinePlus : 001426 eMedicine : neuro/356 Orphanet : 3205 sturge_weber at NINDS v t e Phakomatosis Angiomatosis Sturge–Weber syndrome Von Hippel–Lindau disease Hamartoma Tuberous sclerosis Hypothalamic hamartoma ( Pallister–Hall syndrome ) Multiple hamartoma syndrome Proteus syndrome Cowden syndrome Bannayan–Riley–Ruvalcaba syndrome Lhermitte–Duclos disease Neurofibromatosis Type I Type II Other Abdallat–Davis–Farrage syndrome Ataxia telangiectasia Incontinentia pigmenti Peutz–Jeghers syndrome Encephalocraniocutaneous lipomatosis
    GNAQ, RASA1, FN1, PNPLA6, LIFR, ALDH18A1, PIK3CG, POSTN, SNAP29, VEGFA, TSC2, TSC1, TEK, PTPRC, ACHE, PIK3CD, CYP1B1, PIK3CA, NF1, MEF2C, KDR, HIF1A, EDN1, CYP2B6, PIK3CB
    • Sturge-Weber Syndrome Omim
      A number sign (#) is used with this entry because of evidence that Sturge-Weber syndrome can be caused by somatic mosaic mutation in the GNAQ gene (600998) on chromosome 9q21. ... Clinical Features The Klippel-Trenaunay-Weber syndrome (149000) is sometimes associated with SWS (see Bonse, 1951 and Nonnenmacher, 1955). Debicka and Adamczak (1979) described Sturge-Weber syndrome in father and son, both of whom had, in addition to trigeminal angiomatous nevi, evidence of central nervous system involvement. ... Hall et al. (2007) reported 6 patients with phakomatosis pigmentovascularis type II, consisting of nevus flammeus and mongolian spots; 2 patients were diagnosed with Klippel-Trenaunay syndrome, and 3 had features consistent with both Klippel-Trenaunay and Sturge-Weber syndromes. ... Shirley et al. (2013) suggested that nonsyndromic port-wine stains may represent a late origin of the somatic GNAQ mutation in vascular endothelial cells, whereas in Sturge-Weber syndrome, the mutation may occur earlier in development, in progenitor cells that are precursors to a larger variety of cell types and tissues, leading to the syndromic phenotype.
    • Parkes Weber Syndrome Wikipedia
      Parkes Weber syndrome Parkes Weber syndrome is inherited in an autosomal dominant manner. ... PMID 26587303 . ^ a b c d e f g "Parkes Weber Syndrome | Conditions + Treatments" . ^ a b c d e f g h i "Parkes Weber Syndrome | Treatments" . ^ EL-Sobky TA, Elsayed SM, EL Mikkawy DME (2015). "Orthopaedic manifestations of Proteus syndrome in a child with literature update" . ... "Parkes Weber syndrome-Diagnostic and management paradigms: A systematic review". ... Online Mendelian Inheritance in Man (OMIM): PARKES WEBER SYNDROME - 608355 Online Mendelian Inheritance in Man (OMIM): TELANGIECTASIA, HEREDITARY BENIGN - 187260 Online Mendelian Inheritance in Man (OMIM): TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER; HHT - 187300 Online Mendelian Inheritance in Man (OMIM): STURGE-WEBER SYNDROME; SWS - 185300 Online Mendelian Inheritance in Man (OMIM): KLIPPEL-TRENAUNAY-WEBER SYNDROME - 149000 Online Mendelian Inheritance in Man (OMIM): GLOMUVENOUS MALFORMATIONS; GVM - 138000 Online Mendelian Inheritance in Man (OMIM): RAS p21 PROTEIN ACTIVATOR 1; RASA1 - 139150 Online Mendelian Inheritance in Man (OMIM): CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION - 608354 External links [ edit ] Classification D ICD - 9-CM : 759.6 OMIM : 608355 DiseasesDB : 33714 External resources Orphanet : 90307 v t e Deficiencies of intracellular signaling peptides and proteins GTP-binding protein regulators GTPase-activating protein Neurofibromatosis type I Watson syndrome Tuberous sclerosis Guanine nucleotide exchange factor Marinesco–Sjögren syndrome Aarskog–Scott syndrome Juvenile primary lateral sclerosis X-Linked mental retardation 1 G protein Heterotrimeic cAMP / GNAS1 : Pseudopseudohypoparathyroidism Progressive osseous heteroplasia Pseudohypoparathyroidism Albright's hereditary osteodystrophy McCune–Albright syndrome CGL 2 Monomeric RAS: HRAS Costello syndrome KRAS Noonan syndrome 3 KRAS Cardiofaciocutaneous syndrome RAB: RAB7 Charcot–Marie–Tooth disease RAB23 Carpenter syndrome RAB27 Griscelli syndrome type 2 RHO: RAC2 Neutrophil immunodeficiency syndrome ARF : SAR1B Chylomicron retention disease ARL13B Joubert syndrome 8 ARL6 Bardet–Biedl syndrome 3 MAP kinase Cardiofaciocutaneous syndrome Other kinase / phosphatase Tyrosine kinase BTK X-linked agammaglobulinemia ZAP70 ZAP70 deficiency Serine/threonine kinase RPS6KA3 Coffin-Lowry syndrome CHEK2 Li-Fraumeni syndrome 2 IKBKG Incontinentia pigmenti STK11 Peutz–Jeghers syndrome DMPK Myotonic dystrophy 1 ATR Seckel syndrome 1 GRK1 Oguchi disease 2 WNK4 / WNK1 Pseudohypoaldosteronism 2 Tyrosine phosphatase PTEN Bannayan–Riley–Ruvalcaba syndrome Lhermitte–Duclos disease Cowden syndrome Proteus-like syndrome MTM1 X-linked myotubular myopathy PTPN11 Noonan syndrome 1 LEOPARD syndrome Metachondromatosis Signal transducing adaptor proteins EDARADD EDARADD Hypohidrotic ectodermal dysplasia SH3BP2 Cherubism LDB3 Zaspopathy Other NF2 Neurofibromatosis type II NOTCH3 CADASIL PRKAR1A Carney complex PRKAG2 Wolff–Parkinson–White syndrome PRKCSH PRKCSH Polycystic liver disease XIAP XIAP2 See also intracellular signaling peptides and proteins
    • Sturge-Weber Syndrome Gard
      Sturge-Weber syndrome (SWS) is a rare disorder affecting the skin and nervous system. ... Port-wine birthmarks are caused by enlarged blood vessels right underneath the skin. People with Sturge-Weber syndrome also have clusters of abnormal blood vessels between the layers of tissue that cover the brain and spine known as leptomeningeal angiomas.
    • Parkes Weber Syndrome Gard
      Parkes Weber syndrome (PWS) is a rare congenital condition characterized by a large number of abnormal blood vessels. ... There also may be pain in the affected limb and a difference in size between the limbs. Some cases of Parkes Weber syndrome result from mutations in the RASA1 gene, and are inherited in an autosomal dominant manner.
    • Sturge-Weber Syndrome Orphanet
      A rare congenital neurocutaneous syndrome defined by a facial capillary malformation or port-wine birthmark (PWB) associated with cerebral and ocular ipsilateral vascular malformations in most of the cases resulting in variable ocular and neurological complications. ... An increased risk of growth hormone deficiency is reported. Etiology The syndrome is caused by a somatic mosaic mutation in GNAQ (9q21) that codes for the protein guanine nucleotide-binding protein G(q) subunit alpha which is critical to the intracellular signaling of a large group of G protein coupled receptors important to vascular development and function. ... Differential diagnosis The main diagnostic concern is to separate infants with an isolated facial PWB from those with Sturge-Weber syndrome (SWS) brain involvement. Differential diagnosis includes PIK3CA-related overgrowth syndromes, especially megalencephaly-capillary malformation-polymicrogyria (MCAP) syndrome.
    • Sturge-Weber Syndrome Medlineplus
      Sturge-Weber syndrome is a condition that affects the development of certain blood vessels, causing abnormalities in the brain, skin, and eyes from birth. ... These features can vary in severity and not all individuals with Sturge-Weber syndrome have all three features. Most people with Sturge-Weber syndrome are born with a port-wine birthmark. ... Causes Sturge-Weber syndrome is caused by a mutation in the GNAQ gene. ... The GNAQ gene mutation that causes Sturge-Weber syndrome results in the production of a protein with impaired function. ... The enhanced signaling likely disrupts the regulation of blood vessel development, causing abnormal and excessive formation of vessels before birth in people with Sturge-Weber syndrome. Learn more about the gene associated with Sturge-Weber syndrome GNAQ Inheritance Pattern Sturge-Weber syndrome is not inherited.
  • X-Linked Lymphoproliferative Disease Wikipedia
    X-linked lymphoproliferative disease Other names Duncan's disease Specialty Hematology X-linked lymphoproliferative disease (also known as Duncan's disease [1] : 86 or Purtilo syndrome [2] ) is a lymphoproliferative disorder . [3] Contents 1 Presentation 2 Cause 2.1 XLP1 2.2 XLP2 3 Diagnosis 4 Treatment 5 Eponym 6 References 7 External links Presentation [ edit ] Strangely, in boys with X-linked lymphoproliferative disorder, there is an inability to mount an immune response to the Epstein-Barr virus (EBV), [4] which often leads to death from bone marrow failure, irreversible hepatitis, and malignant lymphoma. ... You can help by adding to it . ( December 2017 ) Eponym [ edit ] It is also known as Duncan Disease, after 6 of 18 males in the Duncan family died of lymphoproliferative disease, including fulminant infectious mononucleosis and lymphoma . [11] It is also called "Purtilo's Syndrome", after Dr. David Theodore Purtilo (1939–1992), a pioneering Pathologist and Immunologist at the American Army Center for Pathology in Washington, who discovered it in the early 1970s. ... Philadelphia: Elsevier Saunders. ^ X-linked Lymphoproliferative Syndrome at Merck Manual of Diagnosis and Therapy Professional Edition ^ Rigaud S, Fondanèche MC, Lambert N, et al. ... "XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome". Nature . 444 (7115): 110–4. Bibcode : 2006Natur.444..110R . doi : 10.1038/nature05257 . ... N Engl J Med 1974; 291:736. ^ https://www.nytimes.com/1992/10/03/us/david-t-purtilo-53-a-specialist-in-disorders-of-the-immune-system.html External links [ edit ] GeneReview/NIH/UW entry on Lymphoproliferative Disease, X-Linked Classification D ICD - 10 : D82.3 OMIM : 308240 300635 MeSH : D008232 DiseasesDB : 3998 External resources eMedicine : med/1370 GeneReviews : Lymphoproliferative Disease, X-Linked Orphanet : 2442 v t e X-linked disorders X-linked recessive Immune Chronic granulomatous disease (CYBB) Wiskott–Aldrich syndrome X-linked severe combined immunodeficiency X-linked agammaglobulinemia Hyper-IgM syndrome type 1 IPEX X-linked lymphoproliferative disease Properdin deficiency Hematologic Haemophilia A Haemophilia B X-linked sideroblastic anemia Endocrine Androgen insensitivity syndrome / Spinal and bulbar muscular atrophy KAL1 Kallmann syndrome X-linked adrenal hypoplasia congenita Metabolic Amino acid : Ornithine transcarbamylase deficiency Oculocerebrorenal syndrome Dyslipidemia : Adrenoleukodystrophy Carbohydrate metabolism : Glucose-6-phosphate dehydrogenase deficiency Pyruvate dehydrogenase deficiency Danon disease/glycogen storage disease Type IIb Lipid storage disorder : Fabry's disease Mucopolysaccharidosis : Hunter syndrome Purine–pyrimidine metabolism : Lesch–Nyhan syndrome Mineral : Menkes disease / Occipital horn syndrome Nervous system X-linked intellectual disability : Coffin–Lowry syndrome MASA syndrome Alpha-thalassemia mental retardation syndrome Siderius X-linked mental retardation syndrome Eye disorders: Color blindness (red and green, but not blue) Ocular albinism ( 1 ) Norrie disease Choroideremia Other: Charcot–Marie–Tooth disease (CMTX2-3) Pelizaeus–Merzbacher disease SMAX2 Skin and related tissue Dyskeratosis congenita Hypohidrotic ectodermal dysplasia (EDA) X-linked ichthyosis X-linked endothelial corneal dystrophy Neuromuscular Becker's muscular dystrophy / Duchenne Centronuclear myopathy (MTM1) Conradi–Hünermann syndrome Emery–Dreifuss muscular dystrophy 1 Urologic Alport syndrome Dent's disease X-linked nephrogenic diabetes insipidus Bone / tooth AMELX Amelogenesis imperfecta No primary system Barth syndrome McLeod syndrome Smith–Fineman–Myers syndrome Simpson–Golabi–Behmel syndrome Mohr–Tranebjærg syndrome Nasodigitoacoustic syndrome X-linked dominant X-linked hypophosphatemia Focal dermal hypoplasia Fragile X syndrome Aicardi syndrome Incontinentia pigmenti Rett syndrome CHILD syndrome Lujan–Fryns syndrome Orofaciodigital syndrome 1 Craniofrontonasal dysplasia v t e Leukaemias , lymphomas and related disease B cell ( lymphoma , leukemia ) (most CD19 CD20 ) By development/ marker TdT+ ALL ( Precursor B acute lymphoblastic leukemia/lymphoma ) CD5 + naive B cell ( CLL/SLL ) mantle zone ( Mantle cell ) CD22 + Prolymphocytic CD11c+ ( Hairy cell leukemia ) CD79a + germinal center / follicular B cell ( Follicular Burkitt's GCB DLBCL Primary cutaneous follicle center lymphoma ) marginal zone / marginal zone B-cell ( Splenic marginal zone MALT Nodal marginal zone Primary cutaneous marginal zone lymphoma ) RS ( CD15 +, CD30 +) Classic Hodgkin lymphoma ( Nodular sclerosis ) CD20+ ( Nodular lymphocyte predominant Hodgkin lymphoma ) PCDs / PP ( CD38 +/ CD138 +) see immunoproliferative immunoglobulin disorders By infection KSHV ( Primary effusion ) EBV Lymphomatoid granulomatosis Post-transplant lymphoproliferative disorder Classic Hodgkin lymphoma Burkitt's lymphoma HCV Splenic marginal zone lymphoma HIV ( AIDS-related lymphoma ) Helicobacter pylori ( MALT lymphoma ) Cutaneous Diffuse large B-cell lymphoma Intravascular large B-cell lymphoma Primary cutaneous marginal zone lymphoma Primary cutaneous immunocytoma Plasmacytoma Plasmacytosis Primary cutaneous follicle center lymphoma T/NK T cell ( lymphoma , leukemia ) (most CD3 CD4 CD8 ) By development/ marker TdT+ : ALL ( Precursor T acute lymphoblastic leukemia/lymphoma ) prolymphocyte ( Prolymphocytic ) CD30+ ( Anaplastic large-cell lymphoma Lymphomatoid papulosis type A ) Cutaneous MF+variants indolent: Mycosis fungoides Pagetoid reticulosis Granulomatous slack skin aggressive: Sézary disease Adult T-cell leukemia/lymphoma Non-MF CD30 -: Non-mycosis fungoides CD30− cutaneous large T-cell lymphoma Pleomorphic T-cell lymphoma Lymphomatoid papulosis type B CD30 +: CD30+ cutaneous T-cell lymphoma Secondary cutaneous CD30+ large-cell lymphoma Lymphomatoid papulosis type A Other peripheral Hepatosplenic Angioimmunoblastic Enteropathy-associated T-cell lymphoma Peripheral T-cell lymphoma not otherwise specified ( Lennert lymphoma ) Subcutaneous T-cell lymphoma By infection HTLV-1 ( Adult T-cell leukemia/lymphoma ) NK cell / (most CD56 ) Aggressive NK-cell leukemia Blastic NK cell lymphoma T or NK EBV ( Extranodal NK-T-cell lymphoma / Angiocentric lymphoma ) Large granular lymphocytic leukemia Lymphoid+ myeloid Acute biphenotypic leukaemia Lymphocytosis Lymphoproliferative disorders ( X-linked lymphoproliferative disease Autoimmune lymphoproliferative syndrome ) Leukemoid reaction Diffuse infiltrative lymphocytosis syndrome Cutaneous lymphoid hyperplasia Cutaneous lymphoid hyperplasia with bandlike and perivascular patterns with nodular pattern Jessner lymphocytic infiltrate of the skin General Hematological malignancy leukemia Lymphoproliferative disorders Lymphoid leukemias v t e Deficiencies of intracellular signaling peptides and proteins GTP-binding protein regulators GTPase-activating protein Neurofibromatosis type I Watson syndrome Tuberous sclerosis Guanine nucleotide exchange factor Marinesco–Sjögren syndrome Aarskog–Scott syndrome Juvenile primary lateral sclerosis X-Linked mental retardation 1 G protein Heterotrimeic cAMP / GNAS1 : Pseudopseudohypoparathyroidism Progressive osseous heteroplasia Pseudohypoparathyroidism Albright's hereditary osteodystrophy McCune–Albright syndrome CGL 2 Monomeric RAS: HRAS Costello syndrome KRAS Noonan syndrome 3 KRAS Cardiofaciocutaneous syndrome RAB: RAB7 Charcot–Marie–Tooth disease RAB23 Carpenter syndrome RAB27 Griscelli syndrome type 2 RHO: RAC2 Neutrophil immunodeficiency syndrome ARF : SAR1B Chylomicron retention disease ARL13B Joubert syndrome 8 ARL6 Bardet–Biedl syndrome 3 MAP kinase Cardiofaciocutaneous syndrome Other kinase / phosphatase Tyrosine kinase BTK X-linked agammaglobulinemia ZAP70 ZAP70 deficiency Serine/threonine kinase RPS6KA3 Coffin-Lowry syndrome CHEK2 Li-Fraumeni syndrome 2 IKBKG Incontinentia pigmenti STK11 Peutz–Jeghers syndrome DMPK Myotonic dystrophy 1 ATR Seckel syndrome 1 GRK1 Oguchi disease 2 WNK4 / WNK1 Pseudohypoaldosteronism 2 Tyrosine phosphatase PTEN Bannayan–Riley–Ruvalcaba syndrome Lhermitte–Duclos disease Cowden syndrome Proteus-like syndrome MTM1 X-linked myotubular myopathy PTPN11 Noonan syndrome 1 LEOPARD syndrome Metachondromatosis Signal transducing adaptor proteins EDARADD EDARADD Hypohidrotic ectodermal dysplasia SH3BP2 Cherubism LDB3 Zaspopathy Other NF2 Neurofibromatosis type II NOTCH3 CADASIL PRKAR1A Carney complex PRKAG2 Wolff–Parkinson–White syndrome PRKCSH PRKCSH Polycystic liver disease XIAP XIAP2 See also intracellular signaling peptides and proteins
    SH2D1A, IL17A, XIAP, IFNG, STAG2, SLAMF1, APCS, IL10, HPRT1, ITK, RTEL1, CD244, CD1D, ICOS, CCR4, TRBV20OR9-2, NR0B2, CD84, TENM1, HPGDS, IL22, RAB27A, FOXP3, AP5M1, NLRC4, IL21, SLAMF6, VPS13B, CD2, PTPN6, PTPN11, IL2RG, DOK1, FUT1, HLA-DQB1, LYST, IL1A, IL1B, IL1RN, IL4, CYBB, IL7R, CD40LG, INS, CD27, PDCD1, SERPINA4, PLCG1, NCF1
    • Lymphoproliferative Syndrome, X-Linked, 2 Omim
      A number sign (#) is used with this entry because of evidence that X-linked lymphoproliferative syndrome-2 (XLP2) is caused by mutation in the gene encoding the X-linked inhibitor of apoptosis (XIAP; 300079) on chromosome Xq25. ... For a general phenotypic description and a discussion of genetic heterogeneity of X-linked lymphoproliferative syndrome, see XLP1 (308240). Clinical Features Rigaud et al. (2006) reported 12 male patients from 3 unrelated families with XLP2. ... Six of 7 female carriers were affected to varying degrees with erythema nodosum (EN) and/or variable bowel symptoms, including IBD and irritable bowel syndrome. Yang et al. (2015) reported a Japanese family in which 3 sibs, 2 boys and a girl, had manifestations of XLP2.
    • X-Linked Lymphoproliferative Syndrome Gard
      X-linked lymphoproliferative syndrome (XLP) is an immune system disorder that occurs almost exclusively in males.
    • Lymphoproliferative Syndrome, X-Linked, 1 Omim
      A number sign (#) is used with this entry because X-linked lymphoproliferative syndrome-1 (XLP1) is caused by mutation in the SH2D1A gene (300490), encoding SLAM-associated protein (SAP), on chromosome Xq25. Description X-linked lymphoproliferative syndrome, or Duncan disease, is a primary immunodeficiency characterized by severe immune dysregulation often after viral infection, typically with Epstein-Barr virus (EBV). ... The patient presented with virus-associated hemophagocytic syndrome, and later chorioretinitis, bronchiectasis, and hypogammaglobulinemia developed. ... One of their patients was found to have the Klinefelter syndrome, having inherited 2 copies of his maternal XLPD-carrying X chromosome. ... Molecular Genetics In 9 unrelated patients with X-linked lymphoproliferative syndrome, Coffey et al. (1998) identified mutations in the SH2D1A gene (300490.0001-300490.0009).
  • Follicular Thyroid Cancer Wikipedia
    Contents 1 Cause 1.1 Associated mutations 2 Hurthle cell variant 3 Diagnosis 3.1 Classification 4 Treatment 4.1 Initial treatment 4.2 Finding disease recurrence 5 Prognosis 6 References 7 External links Cause [ edit ] Associated mutations [ edit ] Approximately one-half of follicular thyroid carcinomas have mutations in the Ras subfamily of oncogenes, most notably HRAS , NRAS , and KRAS . [1] Mutations in MINPP1 have likewise been observed, as well as germline PTEN gene mutations responsible for Cowden syndrome of which follicular thyroid cancer is a feature.
    THRB, NRAS, HRAS, PTEN, KRAS, DIRAS3, PRKAR1A, PIK3CA, AKT1, SDHD, MINPP1, TP53, TAS2R38, FOXE1, PTCH1, HABP2, PPARG, SRGAP1, CCDC6, PIK3CG, PIK3CD, PIK3CB, F9, RET, PAX8, KLLN, SDHC, SEC23B, SDHB, BRAF, TG, TSHR, TERT, LOC110806263, RASSF1, VEGFA, EGF, MIR146B, DPP4, SLC5A5, BRCA1, KDR, CTNNB1, LGALS3, HIF1A, CD274, NME1, PROX1, FLT1, RAPGEF3, SGSM3, MMP9, RASAL1, SRY, H2AX, CLDN1, IDH1, MMP2, PTGS2, TPCN1, TPT1, YY1, APC, MIR146A, EGFR, CLDN7, MIR21, NKX2-1, TFF3, MIR199B, ST8SIA4, TIE1, THBS1, BUB3, TGFB1, TAF1, STK11, KL, RPH3AL, STC1, SQSTM1, PER2, SPHK1, TNF, TPM3, FCGBP, CDK5R1, VDR, IQGAP1, VEGFC, TNFSF10, MADD, CAVIN2, FZD1, HMGA2, EZR, VIM, GDF15, HCP5, BMS1, KLB, ATF7IP, MIB1, ACE2, LIMD2, COL18A1, RASSF5, MRO, ST6GAL2, HTRA3, PRRT2, NIBAN1, CYP2R1, HT, TICAM1, ANO5, RAB23, TMED10P1, IYD, MIR10B, MIR183, MIR197, MIR19A, MIR221, MIR346, MIR885, MIR4299, HOTAIRM1, H3P9, H3P17, H3P47, DUOX1, ABI3, TSHZ1, RAPGEF4, C1D, CIB1, MRPL28, TXNRD2, ST6GALNAC2, PDPN, POSTN, SPINT2, KHDRBS1, PTGES3, SUB1, RAB40B, TMED10, OGFR, CORO1A, DCTN4, CHEK2, SMG1, TBC1D9, DICER1, QPRT, NUP62, SOSTDC1, NUPR1, ST6GALNAC4, DLL1, HIPK2, NXT1, DUOX2, ANGPTL4, SST, ACACA, SPINT1, FGF2, DIO1, DIO2, DPEP1, DUSP5, E2F1, ERBB2, ERCC1, ESR2, ETS1, ETV6, EVPL, EZH2, FBN1, FGFR4, CYP27B1, FHIT, FOXO3, FLT3, FOLH1, FOSB, MTOR, GDF10, GJB2, GPC3, GOT2, UTS2R, GPER1, GTF2H1, ACE, CYP24A1, SOD2, CAD, ANPEP, ANXA2, XIAP, APLP2, APP, AQP7, AR, ARNTL, ATM, BNIP3, BSG, BUB1, BUB1B, CAV1, CCN2, CAV2, CCND2, SCARB1, CD44, CD68, CDKN1B, CDKN1C, CDKN2A, CDKN2B, CEACAM5, CGA, CLDN4, CRY2, HGF, HLA-G, HMBS, HTRA1, OGG1, OGN, PA2G4, SERPINE1, PCSK2, ENPP2, ABCB1, PHB, SERPINB5, PLG, PRKCA, PRKCB, MAPK3, PSMB6, NR4A1, ACTN4, PTK2, RAP1A, RAP1B, RARA, RRAS, RRM2, S100A10, SCT, CCL15, CXCL12, SLC2A1, SLC2A3, NTRK1, NTHL1, NOTCH3, NOTCH1, HSPA9, HSP90AA1, TNC, ICAM1, IDH2, IGF1R, IGFBP6, IGFBP7, IL1A, IL1B, IL6, CXCL8, CXCR1, IL13RA2, INS, INSL3, IRAK1, ITGA6, ITGAV, STT3A, BCAM, MKI67, MMP1, MT1G, MT1M, NCAM1, NNMT, H3P10
  • Carpenter Syndrome Wikipedia
    Teeth are usually very late to come in and will be undersized and spaced far apart (Carpenter Syndrome-description). Other physical abnormalities often associated with Carpenter Syndrome include extra digits. ... Genetics [ edit ] Carpenter syndrome has an autosomal recessive pattern of inheritance . ... The testes of males affected by Carpenter Syndrome may also fail to descend (Paul A. ... "Craniofacial dysmorphology of Carpenter syndrome: lessons from three affected siblings". ... PMID 23063620 . ^ a b Paul A. Johnson, 2002 ^ Carpenter Syndrom-What is it?, 2007 External links [ edit ] Classification D ICD - 10 : Q87.0 OMIM : 201000 MeSH : C563187 C563187, C563187 DiseasesDB : 29583 SNOMED CT : 205813009 External resources Orphanet : 65759 v t e Congenital abnormality syndromes Craniofacial Acrocephalosyndactylia Apert syndrome Carpenter syndrome Pfeiffer syndrome Saethre–Chotzen syndrome Sakati–Nyhan–Tisdale syndrome Bonnet–Dechaume–Blanc syndrome Other Baller–Gerold syndrome Cyclopia Goldenhar syndrome Möbius syndrome Short stature 1q21.1 deletion syndrome Aarskog–Scott syndrome Cockayne syndrome Cornelia de Lange syndrome Dubowitz syndrome Noonan syndrome Robinow syndrome Silver–Russell syndrome Seckel syndrome Smith–Lemli–Opitz syndrome Snyder–Robinson syndrome Turner syndrome Limbs Adducted thumb syndrome Holt–Oram syndrome Klippel–Trénaunay–Weber syndrome Nail–patella syndrome Rubinstein–Taybi syndrome Gastrulation / mesoderm : Caudal regression syndrome Ectromelia Sirenomelia VACTERL association Overgrowth syndromes Beckwith–Wiedemann syndrome Proteus syndrome Perlman syndrome Sotos syndrome Weaver syndrome Klippel–Trénaunay–Weber syndrome Benign symmetric lipomatosis Bannayan–Riley–Ruvalcaba syndrome Neurofibromatosis type I Laurence–Moon–Bardet–Biedl Bardet–Biedl syndrome Laurence–Moon syndrome Combined/other, known locus 2 ( Feingold syndrome ) 3 ( Zimmermann–Laband syndrome ) 4 / 13 ( Fraser syndrome ) 8 ( Branchio-oto-renal syndrome , CHARGE syndrome ) 12 ( Keutel syndrome , Timothy syndrome ) 15 ( Marfan syndrome ) 19 ( Donohue syndrome ) Multiple Fryns syndrome v t e Deficiencies of intracellular signaling peptides and proteins GTP-binding protein regulators GTPase-activating protein Neurofibromatosis type I Watson syndrome Tuberous sclerosis Guanine nucleotide exchange factor Marinesco–Sjögren syndrome Aarskog–Scott syndrome Juvenile primary lateral sclerosis X-Linked mental retardation 1 G protein Heterotrimeic cAMP / GNAS1 : Pseudopseudohypoparathyroidism Progressive osseous heteroplasia Pseudohypoparathyroidism Albright's hereditary osteodystrophy McCune–Albright syndrome CGL 2 Monomeric RAS: HRAS Costello syndrome KRAS Noonan syndrome 3 KRAS Cardiofaciocutaneous syndrome RAB: RAB7 Charcot–Marie–Tooth disease RAB23 Carpenter syndrome RAB27 Griscelli syndrome type 2 RHO: RAC2 Neutrophil immunodeficiency syndrome ARF : SAR1B Chylomicron retention disease ARL13B Joubert syndrome 8 ARL6 Bardet–Biedl syndrome 3 MAP kinase Cardiofaciocutaneous syndrome Other kinase / phosphatase Tyrosine kinase BTK X-linked agammaglobulinemia ZAP70 ZAP70 deficiency Serine/threonine kinase RPS6KA3 Coffin-Lowry syndrome CHEK2 Li-Fraumeni syndrome 2 IKBKG Incontinentia pigmenti STK11 Peutz–Jeghers syndrome DMPK Myotonic dystrophy 1 ATR Seckel syndrome 1 GRK1 Oguchi disease 2 WNK4 / WNK1 Pseudohypoaldosteronism 2 Tyrosine phosphatase PTEN Bannayan–Riley–Ruvalcaba syndrome Lhermitte–Duclos disease Cowden syndrome Proteus-like syndrome MTM1 X-linked myotubular myopathy PTPN11 Noonan syndrome 1 LEOPARD syndrome Metachondromatosis Signal transducing adaptor proteins EDARADD EDARADD Hypohidrotic ectodermal dysplasia SH3BP2 Cherubism LDB3 Zaspopathy Other NF2 Neurofibromatosis type II NOTCH3 CADASIL PRKAR1A Carney complex PRKAG2 Wolff–Parkinson–White syndrome PRKCSH PRKCSH Polycystic liver disease XIAP XIAP2 See also intracellular signaling peptides and proteins
    MEGF8, RAB23, ATRX, GLI3, ZC4H2, AASDHPPT, ARL13B
    • Carpenter Syndrome 2 Omim
      A number sign (#) is used with this entry because of evidence that Carpenter syndrome-2 (CRPT2) is caused by homozygous or compound heterozygous mutation in the MEGF8 gene (604267) on chromosome 19q13. ... For a discussion of genetic heterogeneity of Carpenter syndrome, see 201000. Clinical Features Altunhan et al. (2011) described a Turkish boy who was born with acrocephaly and a peculiar facies characterized by frontal bossing. ... Altunhan et al. (2011) stated that this was the first report of Carpenter syndrome in association with situs inversus totalis. Twigg et al. (2012) studied 5 patients with mutation in the MEGF8 gene and a phenotype closely resembling classic Carpenter syndrome (CRPT1; 201000). One of the patients was the Turkish boy previously described by Altunhan et al. (2011). ... Noting that 3 of the mutation-positive patients also had complete situs inversus, dextrocardia, or transposition of the great arteries, respectively, Twigg et al. (2012) concluded that mutation in MEGF8 causes a Carpenter syndrome subtype frequently associated with defective left-right patterning.
    • Carpenter Syndrome 1 Omim
      Genetic Heterogeneity of Carpenter Syndrome Carpenter syndrome-2 (CRPT2; 614976), in which the features of Carpenter syndrome are sometimes associated with defective lateralization, is caused by mutation in the MEGF8 gene (604267). ... This experience and a review of the literature suggested that the Goodman syndrome (201020) and the Summitt syndrome (272350) fall well within the clinical spectrum of the Carpenter syndrome. ... Gershoni-Baruch (1990) suggested that polysyndactyly is not an absolute requisite for the diagnosis of Carpenter syndrome and that the Summitt and Goodman syndromes are 'within the clinical spectrum' of Carpenter syndrome, as suggested by Cohen et al. (1987). ... Nomenclature The designation of Carpenter syndrome as ACPS II is a relict of an earlier classification that made the Noack syndrome ACPS I. It is now agreed by most that Noack syndrome is the same as Pfeiffer syndrome (101600).
    • Carpenter Syndrome Orphanet
      A rare syndromic craniosynostosis with variable phenotypic expression characterized by craniosynostosis, intellectual disability, distinctive facies, abnormalities of the fingers and toes (brachydactyly, polydactyly and syndactyly), short stature, congenital heart disease, skeletal defects, obesity, genital abnormalities and umbilical hernia. ... Situs inversus, dextrocardia, and polysplenia has been observed in a few patients. Etiology The syndrome is caused by truncating, misssense and loss of function mutations in two different genes RAB23 gene (6p12.1) and less commonly MEGF8 gene (19q13.2). ... Differential diagnosis Differential diagnosis includes other acrocephalosyndactyly disorders, as well as Gorlin syndrome, Apert syndrome and Greig cephalopolysyndactyly syndrome. Ciliopathy disorders also have overlapping features including the wide clinical variability and features such as obesity and polydactyly. Summitt syndrome and Goodman syndrome falls within the clinical spectrum of Carpenter syndrome. ... Management and treatment Multidisciplinary management and treatment is required. Most patients with this syndrome will undergo early craniofacial reconstruction to improve appearance and prevent intellectual disability.
    • Carpenter Syndrome Gard
      Carpenter syndrome is a condition characterized by premature fusion of skull bones (craniosynostosis); finger and toe abnormalities; and other developmental problems. ... Other signs and symptoms may include dental abnormalities; vision problems; hearing loss; heart defects; genital abnormalities; obesity; various skeletal abnormalities; and a range of intellectual disability. Carpenter syndrome can be caused by mutations in the RAB23 or MEGF8 gene and is inherited in an autosomal recessive manner.
  • Bardet–biedl Syndrome Wikipedia
    "Laurence-Moon-Biedl syndrome" and "Laurence-Moon-Biedl-Bardet" redirect here. Not to be confused with Laurence–Moon syndrome . Bardet–Biedl syndrome Other names Biedl-Bardet Syndrome [1] This condition is often inherited via autosomal recessive manner (including digenic recessive); but epigenetic phennomena also cause some of the variation seen in BBS Specialty Medical genetics Bardet–Biedl syndrome ( BBS ) is a ciliopathic human genetic disorder that produces many effects and affects many body systems. ... Laurence–Moon syndrome is usually considered a separate entity. ... The Clinical, Molecular, and Functional Genetics of Bardet–Biedl Syndrome , in Genetics of Obesity Syndromes . ... External links [ edit ] Classification D ICD - 10 : Q87.8 ICD - 9-CM : 759.89 OMIM : 209900 MeSH : D020788 DiseasesDB : 7286 External resources GeneReviews : Bardet-Biedl Syndrome Orphanet : 110 Overview at United States National Library of Medicine Molecular diagnosis at NCBI v t e Congenital abnormality syndromes Craniofacial Acrocephalosyndactylia Apert syndrome Carpenter syndrome Pfeiffer syndrome Saethre–Chotzen syndrome Sakati–Nyhan–Tisdale syndrome Bonnet–Dechaume–Blanc syndrome Other Baller–Gerold syndrome Cyclopia Goldenhar syndrome Möbius syndrome Short stature 1q21.1 deletion syndrome Aarskog–Scott syndrome Cockayne syndrome Cornelia de Lange syndrome Dubowitz syndrome Noonan syndrome Robinow syndrome Silver–Russell syndrome Seckel syndrome Smith–Lemli–Opitz syndrome Snyder–Robinson syndrome Turner syndrome Limbs Adducted thumb syndrome Holt–Oram syndrome Klippel–Trénaunay–Weber syndrome Nail–patella syndrome Rubinstein–Taybi syndrome Gastrulation / mesoderm : Caudal regression syndrome Ectromelia Sirenomelia VACTERL association Overgrowth syndromes Beckwith–Wiedemann syndrome Proteus syndrome Perlman syndrome Sotos syndrome Weaver syndrome Klippel–Trénaunay–Weber syndrome Benign symmetric lipomatosis Bannayan–Riley–Ruvalcaba syndrome Neurofibromatosis type I Laurence–Moon–Bardet–Biedl Bardet–Biedl syndrome Laurence–Moon syndrome Combined/other, known locus 2 ( Feingold syndrome ) 3 ( Zimmermann–Laband syndrome ) 4 / 13 ( Fraser syndrome ) 8 ( Branchio-oto-renal syndrome , CHARGE syndrome ) 12 ( Keutel syndrome , Timothy syndrome ) 15 ( Marfan syndrome ) 19 ( Donohue syndrome ) Multiple Fryns syndrome v t e Diseases of cilia Structural receptor: Polycystic kidney disease cargo: Asphyxiating thoracic dysplasia basal body : Bardet–Biedl syndrome mitotic spindle : Meckel syndrome centrosome : Joubert syndrome Signaling Nephronophthisis Other/ungrouped Alström syndrome Primary ciliary dyskinesia Senior–Løken syndrome Orofaciodigital syndrome 1 McKusick–Kaufman syndrome Autosomal recessive polycystic kidney See also: ciliary proteins v t e Deficiencies of intracellular signaling peptides and proteins GTP-binding protein regulators GTPase-activating protein Neurofibromatosis type I Watson syndrome Tuberous sclerosis Guanine nucleotide exchange factor Marinesco–Sjögren syndrome Aarskog–Scott syndrome Juvenile primary lateral sclerosis X-Linked mental retardation 1 G protein Heterotrimeic cAMP / GNAS1 : Pseudopseudohypoparathyroidism Progressive osseous heteroplasia Pseudohypoparathyroidism Albright's hereditary osteodystrophy McCune–Albright syndrome CGL 2 Monomeric RAS: HRAS Costello syndrome KRAS Noonan syndrome 3 KRAS Cardiofaciocutaneous syndrome RAB: RAB7 Charcot–Marie–Tooth disease RAB23 Carpenter syndrome RAB27 Griscelli syndrome type 2 RHO: RAC2 Neutrophil immunodeficiency syndrome ARF : SAR1B Chylomicron retention disease ARL13B Joubert syndrome 8 ARL6 Bardet–Biedl syndrome 3 MAP kinase Cardiofaciocutaneous syndrome Other kinase / phosphatase Tyrosine kinase BTK X-linked agammaglobulinemia ZAP70 ZAP70 deficiency Serine/threonine kinase RPS6KA3 Coffin-Lowry syndrome CHEK2 Li-Fraumeni syndrome 2 IKBKG Incontinentia pigmenti STK11 Peutz–Jeghers syndrome DMPK Myotonic dystrophy 1 ATR Seckel syndrome 1 GRK1 Oguchi disease 2 WNK4 / WNK1 Pseudohypoaldosteronism 2 Tyrosine phosphatase PTEN Bannayan–Riley–Ruvalcaba syndrome Lhermitte–Duclos disease Cowden syndrome Proteus-like syndrome MTM1 X-linked myotubular myopathy PTPN11 Noonan syndrome 1 LEOPARD syndrome Metachondromatosis Signal transducing adaptor proteins EDARADD EDARADD Hypohidrotic ectodermal dysplasia SH3BP2 Cherubism LDB3 Zaspopathy Other NF2 Neurofibromatosis type II NOTCH3 CADASIL PRKAR1A Carney complex PRKAG2 Wolff–Parkinson–White syndrome PRKCSH PRKCSH Polycystic liver disease XIAP XIAP2 See also intracellular signaling peptides and proteins
    MKS1, BBS10, SDCCAG8, LZTFL1, BBIP1, CEP290, ARL6, IFT27, BBS2, MKKS, BBS4, BBS1, TTC8, ALMS1, IFT172, C8orf37, NPHP1, TMEM67, TBC1D32, BBS7, TRIM32, BBS9, BBS5, BBS12, TRAPPC3, ASTN2, PIGX, CEP19, ZDHHC24, CCDC28B, LEP, GLIS2, RTEL1, PLLP, PYY3, SULT1A4, PEG13, AZIN1, STOML3, RIN2, MAGEL2, CBLL2, MARVELD2, MYO3B, INPP5E, USP35, MUL1, WDPCP, IFT74, CEP131, SCAPER, INVS, NPY2R, NPY, NMB, NDN, MYO9A, MYO7A, RAB8A, KIFC3, KIF2A, INSR, IL18, GPT, GFAP, ERG, CCT, TNFRSF11B, PRKN, PCM1, ADIPOQ, CEP164, STUB1, FEM1B, RAPGEF5, IQCB1, FEZ1, TRPV1, PDE6B, VEGFA, SULT1A3, RHO, RFX1, RCVRN, PECAM1, SLX1A-SULT1A3
    • Bardet-Biedl Syndrome 21 Omim
      A number sign (#) is used with this entry because of evidence that Bardet-Biedl syndrome-21 (BBS21) is caused by homozygous mutation in the C8ORF37 gene (614477) on chromosome 8q22. ... For a general phenotypic description and a discussion of genetic heterogeneity of Bardet-Biedl syndrome, see BBS1 (209900). Clinical Features Heon et al. (2016) studied a 17-year-old Caucasian girl, born to consanguineous parents, who exhibited features that met the diagnostic criteria for Bardet-Biedl syndrome (BBS), including slowly progressive rod-cone dystrophy, 3-limb postaxial polydactyly, near-obesity (BMI, 29.1), mild learning difficulty, abnormally positioned uterus, and horseshoe kidney. ... Based on the presence of 3 primary features of BBS (retinal dystrophy, polydactyly, and obesity) and 2 secondary features (speech delay and abnormal dentition), the patient was diagnosed with Bardet-Biedl syndrome. Khan et al. (2016) noted that this patient exhibited cone-rod dystrophy, rather than the rod-cone dystrophy more commonly associated with BBS.
    • Bardet-Biedl Syndrome 4 Omim
      A number sign (#) is used with this entry because Bardet-Biedl syndrome-4 (BBS4) is caused by homozygous mutation in the BBS4 gene (600374) on chromosome 15q24. ... For a general phenotypic description and a discussion of genetic heterogeneity of Bardet-Biedl syndrome, see BBS1 (209900). Clinical Features Iannaccone et al. (2005) described 3 patients with BBS4 from an Italian family (Mykytyn et al., 2001). ... Mapping Carmi et al. (1995) used a DNA pooling approach with DNA samples from a highly inbred Bedouin kindred to identify a Bardet-Biedl syndrome locus on chromosome 15. Homozygosity mapping using pooled DNA samples assumes that all or most of the affected individuals share a common chromosomal region inherited from a common ancestral founder.
    • Bardet-Biedl Syndrome 1 Omim
      Clinical Features Renal abnormalities appear to have a high frequency in the Bardet-Biedl syndrome (Alton and McDonald, 1973). Klein (1978) observed 57 cases of Bardet-Biedl syndrome in Switzerland. ... Gershoni-Baruch et al. (1992) emphasized the occurrence of cystic kidney dysplasia in Bardet-Biedl syndrome. They commented on the fact that the combination of cystic kidney dysplasia and polydactyly occurs also in Meckel syndrome (249000) and in the short rib-polydactyly syndromes (see 613091), and that usually these syndromes are easy to differentiate. ... They suggested the use of the term polydactyly-obesity-kidney-eye syndrome in recognition of what they described as the phenotypic overlap between BBS and Laurence-Moon syndrome. ... Optical coherence tomography confirmed loss of outer retinal structure within the atrophic areas. Relationship to Laurence-Moon Syndrome There has been longstanding uncertainty as to the relationship between the Laurence-Moon syndrome (245800) and the Bardet-Biedl syndrome. ... Putoux et al. (2011) identified 8 different heterozygous missense mutations in the KIF7 gene (611254) in 8 patients with ciliopathies, including Bardet-Biedl syndrome, Meckel syndrome (MKS; 249000), Joubert syndrome (JBTS; 213300), Pallister-Hall syndrome (PHS; 146510), and OFD6 (277170).
    • Bardet-Biedl Syndrome Gard
      Bardet-Biedl syndrome (BBS) is an inherited condition that affects many parts of the body. People with this syndrome have progressive visual impairment due to cone-rod dystrophy ; extra fingers or toes (polydactyly); truncal obesity; decreased function of the male gonads (hypogonadism); kidney abnormalities; and learning difficulties. Mutations in many genes are known to cause Bardet-Biedl syndrome and inheritance is usually autosomal recessive.
    • Bardet-Biedl Syndrome 13 Omim
      A number sign (#) is used with this entry because of evidence that Bardet-Biedl syndrome-13 (BBS13) is caused by compound heterozygous mutation in the MKS1 gene (609883) on chromosome 17q22. ... For a general phenotypic description and a discussion of genetic heterogeneity of Bardet-Biedl syndrome, see BBS1 (209900). Clinical Features Xing et al. (2014) reported a Chinese boy with BBS13. ... Molecular Genetics In a 2-year-old patient of Turkish descent with Bardet-Biedl syndrome, Leitch et al. (2008) identified compound heterozygosity for mutations in the MKS1 gene: a missense mutation (C492W; 609883.0006) and a 3-bp in-frame deletion resulting in deletion of phenylalanine (F371del; 609883.0007). ... Leitch et al. (2008) concluded that their data extended the genetic stratification of ciliopathies and suggested that BBS and Meckel syndrome (see 609883), although distinct clinically, are allelic forms of the same molecular spectrum.
    • Bardet-Biedl Syndrome Orphanet
      Bardet-Biedl syndrome (BBS) is a ciliopathy with multisystem involvement. ... Differential diagnosis The differential diagnosis should include the Alström, McKusick-Kaufmann and Meckel-Gruber syndromes (see these terms). Genetic counseling The disorder is transmitted mainly in an autosomal recessive manner but oligogenic inheritance has been reported in some cases.
    • Bardet-Biedl Syndrome 2 Omim
      A number sign (#) is used with this entry because Bardet-Biedl syndrome-2 (BBS2) is caused by homozygous or compound heterozygous mutations in the BBS2 gene (606151) on chromosome 16q13. ... For a general phenotypic description and a discussion of genetic heterogeneity of Bardet-Biedl syndrome, see BBS1 (209900). Clinical Features Kwitek-Black et al. (1993) studied a large inbred Bedouin family from the Negev region of Israel (pedigree 1) in which Bardet-Biedl syndrome was linked to chromosome 16q21. ... Elbedour et al. (1994) studied 3 Bedouin families with Bardet-Biedl syndrome from the Negev region of Israel, 2 of which had been studied by Kwitek-Black et al. (1993). ... Laurier et al. (2006) identified an extended consanguineous Bardet Biedl syndrome family in which a homozygous mutation in BBS2 (G139V; 606151.0017) was detected in one sibship.
    • Bardet-Biedl Syndrome 17 Omim
      A number sign (#) is used with this entry because Bardet-Biedl syndrome-17 (BBS17) is caused by homozygous or compound heterozygous mutation in the LZTFL1 gene (606568) on chromosome 3p21. ... For a general phenotypic description and a discussion of genetic heterogeneity of Bardet-Biedl syndrome, see BBS1 (209900). Clinical Features Deffert et al. (2007) studied 2 sibs with Bardet-Biedl syndrome (BBS) from a consanguineous Algerian family. ... Molecular Genetics Deffert et al. (2007) did not identify a causative mutation in the BBS1 (209901) through BBS10 (610148) genes in the surviving sib with Bardet-Biedl syndrome from a consanguineous Algerian family. ... Schaefer et al. (2014) identified compound heterozygosity for mutations in the LZTFL1 gene (606568.0002-606568.0003) in dizygotic twin sisters with Bardet-Biedl syndrome. INHERITANCE - Autosomal recessive GROWTH Weight - Obesity HEAD & NECK Eyes - Retinal degeneration - Cone-rod dystrophy CARDIOVASCULAR Heart - Dextrocardia (in some patients) ABDOMEN - Situs inversus (in some patients) GENITOURINARY External Genitalia (Male) - Hypogenitalism - Hypogonadism Kidneys - Cystic kidneys - Chronic renal failure SKELETAL Hands - Polydactyly - Mesoaxial polydactyly - Brachydactyly Feet - Polydactyly NEUROLOGIC Central Nervous System - Delayed development - Learning disabilities - Cognitive impairment MISCELLANEOUS - Two unrelated families have been reported (last curated October 2014) MOLECULAR BASIS - Caused by mutation in the leucine zipper transcription factor-like 1 gene (LZTFL1, 606568.0001 ) ▲ Close
    • Bardet-Biedl Syndrome 3 Omim
      A number sign (#) is used with this entry because Bardet-Biedl syndrome-3 (BBS3) is caused by homozygous mutation in the ARL6 gene (608845) on chromosome 3q11. ... For a general phenotypic description and a discussion of genetic heterogeneity of Bardet-Biedl syndrome, see BBS1 (209900). Clinical Features Sheffield et al. (1994) studied a highly consanguineous 5-generation Bedouin family from the Negev region of Israel with 12 affected members with Bardet-Biedl syndrome. ... Mapping In a large highly consanguineous Bedouin kindred with Bardet-Biedl syndrome (Kwitek-Black et al., 1993), Sheffield et al. (1994) used linkage analysis to map the phenotype to an 11-cM region between D3S1254 and D3S1302. ... They thus demonstrated that there are 2 genetic forms of BBS in the Bedouin population of the Middle East, one determined by a chromosome 16 gene (BBS2; 606151) and one determined by a chromosome 3 gene (BBS3). Linkage of Bardet-Biedl syndrome to chromosome 3 in the kindred studied by Sheffield et al. (1994) was supported by a lod score of 7.52 at theta = 0.0, as well as by the observation of homozygosity in highly informative markers across the candidate region in affected individuals.
    • Bardet-Biedl Syndrome 19 Omim
      A number sign (#) is used with this entry because of evidence that Bardet-Biedl syndrome-19 (BBS19) can be caused by homozygous mutation in the IFT27 gene (615870) on chromosome 22q12. ... For a general phenotypic description and a discussion of genetic heterogeneity of Bardet-Biedl syndrome, see BBS1 (209900). Clinical Features Aldahmesh et al. (2014) reported 2 sibs with BBS from a consanguineous Saudi family.
    • Bardet-Biedl Syndrome 18 Omim
      A number sign (#) is used with this entry because of evidence that Bardet-Biedl syndrome-18 (BBS18) can be caused by homozygous mutation in the BBIP1 gene (613605) on chromosome 10q25. ... For a general phenotypic description and a discussion of genetic heterogeneity of Bardet-Biedl syndrome, see BBS1 (209900). Clinical Features Scheidecker et al. (2014) studied a patient with Bardet-Biedl syndrome (BBS) who was the only affected sib of 4 born to consanguineous Italian parents.
    • Bardet-Biedl Syndrome 16 Omim
      A number sign (#) is used with this entry because Bardet-Biedl syndrome-16 (BBS16) is caused by homozygous or compound heterozygous mutations in the SDCCAG8 gene (613524) on chromosome 1q43. Mutations in the SDCCAG8 gene can also result in Senior-Loken syndrome-7 (613615), an autosomal recessive ciliopathy. ... For a general phenotypic description and a discussion of genetic heterogeneity of Bardet-Biedl syndrome, see BBS1 (209900). Clinical Features Billingsley et al. (2012) studied 2 female sibs of East Indian descent with BBS. ... Molecular Genetics Otto et al. (2010) carried out an independent homozygosity mapping study on 22 consanguineous families diagnosed with Bardet-Biedl syndrome in whom no mutation had been detected in any of the 12 BBS genes known at that time.
    • Bardet-Biedl Syndrome 10 Omim
      A number sign (#) is used with this entry because Bardet-Biedl syndrome-10 (BBS10) is caused by homozygous or compound heterozygous mutation in the BBS10 gene (610148) on chromosome 12q21. ... For a general phenotypic description and a discussion of genetic heterogeneity of Bardet-Biedl syndrome, see BBS1 (209900). Clinical Features In 6 patients with molecularly confirmed BBS, including 3 patients with BBS10, Scheidecker et al. (2015) found a cone-rod pattern of dysfunction. ... In the only affected individual from a sibship within a large consanguineous Lebanese kindred with Bardet-Biedl syndrome reported by Stoetzel et al. (2006), Laurier et al. (2006) found compound heterozygosity for the S311A mutation (610148.0004) and a V11G mutation (610148.0005) in the C12ORF58 gene. ... Putoux et al. (2010) identified homozygous or compound heterozygous BBS10 mutations in 5 of 21 patients with polydactyly and antenatal onset of severe renal cystic anomalies, without the biliary or hepatic abnormalities characteristic of Meckel syndrome (MKS; 249000). The most common mutation was the 1-bp duplication (271dupT) identified by Stoetzel et al. (2006), found on 6 of 10 mutant alleles.
    • Bardet-Biedl Syndrome 9 Omim
      A number sign (#) is used with this entry because Bardet-Biedl syndrome-9 (BBS9) is caused by homozygosity or compound heterozygosity for mutations in the PTHB1 gene (607968) on chromosome 7p14. ... For a general phenotypic description and a discussion of genetic heterogeneity of Bardet-Biedl syndrome, see BBS1 (209900). Clinical Features Abu-Safieh et al. (2012) reported 3 sibs with BBS9 from a consanguineous Arab family.
    • Bardet-Biedl Syndrome 11 Omim
      A number sign (#) is used with this entry because of evidence that Bardet-Biedl syndrome-11 (BBS11) is caused by mutation in the TRIM32 gene (602290) on chromosome 9q33. ... For a general phenotypic description and a discussion of genetic heterogeneity of Bardet-Biedl syndrome, see BBS1 (209900). Molecular Genetics Chiang et al. (2006) studied a consanguineous Bedouin family with 4 sibs with BBS in which linkage studies had failed to identify a disease locus.
    • Bardet-Biedl Syndrome 8 Omim
      A number sign (#) is used with this entry because Bardet-Biedl syndrome-8 (BBS8) is caused by homozygous mutations in the TTC8 gene (608132) on chromosome 14q31. ... For a general phenotypic description and a discussion of genetic heterogeneity of Bardet-Biedl syndrome, see BBS1 (209900). Clinical Features Ansley et al. (2003) identified 3 families, 1 of Pakistani and 2 of Saudi Arabian lineage, with BBS8. ... One of his affected sisters had a presentation suggestive of McKusick-Kaufman syndrome (236700) as she was operated on at birth for hydrometrocolpos.
    • Bardet-Biedl Syndrome 5 Omim
      A number sign (#) is used with this entry because Bardet-Biedl syndrome-5 (BBS5) is caused by homozygous mutation in the BBS5 gene (603650) on chromosome 2q31. ... For a general phenotypic description and a discussion of genetic heterogeneity of Bardet-Biedl syndrome, see BBS1 (209900). Clinical Features Young et al. (1999) reported that in 5 affected members of a BBS5 kindred, related as sibs or first cousins in 3 sibships and of ages varying from 21 to 31 years, none had polydactyly, but all had brachydactyly and/or syndactyly. ... In a 22-year prospective cohort study of 46 patients from 26 Newfoundland families with BBS, Moore et al. (2005) found that 1 patient who had been diagnosed with Laurence-Moon syndrome (245800) was from a consanguineous family with BBS linked to the BBS5 gene.
    • Bardet-Biedl Syndrome 12 Omim
      A number sign (#) is used with this entry because Bardet-Biedl syndrome-12 (BBS12) is caused by homozygous or compound heterozygous mutation in the BBS12 gene (610683) on chromosome 4q27. ... For a general phenotypic description and a discussion of genetic heterogeneity of Bardet-Biedl syndrome, see BBS1 (209900). Clinical Features Dulfer et al. (2010) reported 2 female sibs with BBS resulting from compound heterozygous truncating mutations in the BBS12 gene.
    • Bardet-Biedl Syndrome 14 Omim
      A number sign (#) is used with this entry because of evidence that Bardet-Biedl syndrome-14 (BBS14) is caused by homozygous mutation in the CEP290 gene (610142) on chromosome 12q21. ... For a general phenotypic description and a discussion of genetic heterogeneity of Bardet-Biedl syndrome, see BBS1 (209900). Molecular Genetics In an 11-year-old female with Bardet-Biedl syndrome from a consanguineous Saudi Arabian family, Leitch et al. (2008) identified homozygosity for a nonsense mutation in the CEP290 gene (610142.0013).
    • Bardet-Biedl Syndrome 6 Omim
      A number sign (#) is used with this entry because Bardet-Biedl syndrome-6 (BBS6) is caused by homozygous or compound heterozygous mutation in the MKKS gene (604896) on chromosome 20p12. ... For a general phenotypic description and a discussion of genetic heterogeneity of Bardet-Biedl syndrome, see BBS1 (209900). Clinical Features Slavotinek et al. (2000) described patients from 4 families with BBS6. ... Slavotinek et al. (2000) sought mutations in the MKKS gene because of phenotypic similarities between McKusick-Kaufman syndrome and Bardet-Biedl syndrome. McKusick-Kaufman syndrome (236700) includes hydrometrocolpos, postaxial polydactyly, and congenital heart disease, with autosomal recessive inheritance. ... Given the mapping position and the clinical similarity between McKusick-Kaufman syndrome and Bardet-Biedl syndrome, they screened the MKKS gene and identified mutations in 5 Newfoundland and 2 European-American BBS pedigrees. ... The data suggested that BBS6 is a minor contributor to the syndrome and that some BBS6 alleles may act in conjunction with mutations at other BBS loci to cause or modify the BBS phenotype.
    • Bardet-Biedl Syndrome 20 Omim
      A number sign (#) is used with this entry because of evidence that Bardet-Biedl syndrome-20 (BBS20) is caused by compound heterozygous mutation in the IFT74 gene (608040) on chromosome 9p21. ... For a general phenotypic description and a discussion of genetic heterogeneity of Bardet-Biedl syndrome, see BBS1 (209900). Clinical Features Lindstrand et al. (2016) reported a 36-year-old man (AR672-04) with BBS.
    • Bardet-Biedl Syndrome 15 Omim
      A number sign (#) is used with this entry because Bardet-Biedl syndrome-15 (BBS15) is caused by homozygous mutation in the WDPCP gene (613580) on chromosome 2p15. ... For a general phenotypic description and a discussion of genetic heterogeneity of Bardet-Biedl syndrome, see BBS1 (209900). Molecular Genetics In a patient with a clinical diagnosis of BBS, Kim et al. (2010) identified a homozygous mutation in the WDPCP gene (613580.0001).
    • Bardet-Biedl Syndrome 7 Omim
      A number sign (#) is used with this entry because Bardet-Biedl syndrome-7 (BBS7) is caused by homozygous mutation in the BBS7 gene (607590) on chromosome 4q27. ... For a general phenotypic description and a discussion of genetic heterogeneity of Bardet-Biedl syndrome, see BBS1 (209900). Clinical Features The 4 affected children with BBS7 from the consanguineous family studied by Najmabadi et al. (2011) had severe intellectual disability, polydactyly, and obesity. ... By homozygosity mapping followed by exon enrichment and next-generation sequencing in 136 consanguineous families (over 90% Iranian and less than 10% Turkish or Arabic) segregating syndromic or nonsyndromic forms of autosomal recessive intellectual disability, Najmabadi et al. (2011) identified homozygosity for a 6-bp deletion in the BBS7 gene (607590.0004) in affected members of a family (M324) segregating Bardet-Biedl syndrome.
  • Macrocephaly Wikipedia
    People diagnosed with macrocephaly will have further testing done to determine if the syndrome is accompanied by any other disorders . ... Pathologic macrocephaly is called "syndromic", when it is associated with any other noteworthy condition, and "nonsyndromic" otherwise. Pathologic macrocephaly may be caused by congenital anatomic abnormalities, genetic conditions, or by environmental events. [1] Many genetic conditions are associated with macrocephaly, including familial macrocephaly related to the holgate gene, autism , PTEN mutations such as Cowden disease , neurofibromatosis type 1, and tuberous sclerosis ; overgrowth syndromes such as Sotos syndrome (cerebral gigantism), Weaver syndrome , Simpson-Golabi-Behmel syndrome (bulldog syndrome), and macrocephaly-capillary malformation ( M-CMTC ) syndrome; neurocardiofacial-cutaneous syndromes such as Noonan syndrome , Costello syndrome , Gorlin Syndrome , [2] (also known as Basal Cell Nevus Syndrome) and cardiofaciocutaneous syndrome ; Fragile X syndrome ; leukodystrophies (brain white matter degeneration) such as Alexander disease , Canavan disease , and megalencephalic leukoencephalopathy with subcortical cysts ; and glutaric aciduria type 1 and D-2-hydroxyglutaric aciduria . [1] At one end of the genetic spectrum, duplications of chromosomes have been found to be related to autism and macrocephaly; at the other end, deletions of chromosomes have been found to be related to schizophrenia and microcephaly . [3] [4] [5] Environmental events associated with macrocephaly include infection, neonatal intraventricular hemorrhage (bleeding within the infant brain), subdural hematoma (bleeding beneath the outer lining of the brain), subdural effusion (collection of fluid beneath the outer lining of the brain), and arachnoid cysts (cysts on the brain surface). [1] In research, cranial height or brain imaging may be used to determine intracranial volume more accurately. [1] Below is a list of causes of macrocephaly from Swaiman's pediatric neurology: principles and practice noted in The Little Black Book of Neurology : [6] [7] Hydrocephalus [ edit ] Dandy-Walker malformation Noncommunicating [ edit ] Arnold-Chiari malformation Aqueductal stenosis X-linked hydrocephalus with stenosis of the aqueduct of Sylvius (HSAS) syndrome ( L1CAM ) Dandy-Walker malformation Galenic vein aneurysm or malformation Neoplasms , supratentorial , and infratentorial Arachnoid cyst , infratentorial Holoprosencephaly with dorsal interhemispheric sac Communicating [ edit ] External or extraventricular obstructive hydrocephalus ( dilated subarachnoid space) Arachnoid cyst, supratentorial [ edit ] This section is empty. ... Symptoms vary on the cause of macrocephaly on the child and if the child has any other accompanying syndromes which will be determined through molecular testing. ... Treatment [ edit ] Treatment varies depending on whether or not it occurs with other medical conditions in the child and where cerebrospinal fluid is present. [9] If benign and found between the brain and skull then no surgery is needed. [9] [11] If excess fluid is found between the ventricle spaces in the brain then surgery will be needed. [11] Associated syndromes [ edit ] Below is a list of syndromes associated with macrocephaly that are noted in Signs and Symptoms of Genetic Conditions: A Handbook . [12] Lujan-fryns syndrome Include multiple major and or minor anomalies [ edit ] Acrocallosal Syndrome Apert Syndrome Bannayan-Riley-Ruvalcaba Cardiofaciocutaneous syndrome Chromosome 14 - maternal dismoy Chromosome 22qter deletion Cleidocranial dysostosis Costello syndrome Encephalocraniocutaneous lipomatosis FG syndrome Hailermann-streiff syndrome Hydolethalus syndrome Hypomelanosis syndrome Hypomelanosis of Ito Kelvin Peter anomaly plus syndrome Lujan-fryns syndrome Macrocephaly-CM (MCAP) Marshall-Smith syndrome Neuhauser megalocornea/MR syndrome Neurofibromatosis I Nevoid basal cell carcinoma syndrome Noonan syndrome Ocular-ectodermal syndrome Osteopathia striata - cranial sclerosis Perlman syndrome Ricky Ritscher - schinzel syndrome Robinow syndrome Simpson-golabi-behmel syndrome Sotos syndrome Sturge-Weber syndrome Weaver syndrome Wiedermann-rautenstrauch syndrome Sturge-Weber syndrome Secondary to a metabolic disorder [ edit ] Glutaric aciduria type II GM1 gangliosidosis Hunter syndrome Hurler syndrome MPS VII Sanfilippo syndrome Zellweger syndrome Alexander disease Associated with a skeletal dysplasia [ edit ] Achondroplasia Camptomelic dysplasia Craniodiaphyseal dysplasia Craniometalphyseal dysplasia Hypochondrogenesis Hypochondroplasia Kenny-caffey Kniest syndrome Lenz-majewski Osteogenesis imperfecta III Osteopetrosis, autosomal recessive form Schneckenbecken dysplasia Sclerosteosis Short rib syndrome , beemer-langer type Short rib-polydactyly 2 (majewski type) Spondyleopiphyseal dysplasia congenita Thanatophoric dysplasia Tay-sachs With no obvious physical findings [ edit ] Alexander disease Canavan Cobalamin deficiency (combined methylmalonic aciduria and homocystinuria ) Dandy-Walker malformation Glutaric aciduria I L-2 hydroxglutaric aciduria Megalencephalic leukoencephalopathy Osteogenesis imperfecta IV Osteopathia striata-cranial sclerosis Periventricular heterotopia Sandhoff disease Tay-sachs See also [ edit ] Microcephaly Megalencephaly Hydrocephalus References [ edit ] ^ a b c d Williams CA, Dagli A, Battaglia A (2008).
    HEPACAM
    • Macrocephaly, Benign Familial Omim
      Arbour et al. (1996) measured head size in the parents and sibs of 23 patients with a head circumference more than 2 SD above the mean and with no evidence of hydrocephalus or syndromic associations. In 12 of the 23, some degree of psychomotor impairment was present. ... In the course of a clinical study of Sotos syndrome (117550), Cole and Hughes (1991) found that 6 of 79 probands who failed to fit that phenotype showed remarkable similarities to each other and to some of their first- and second-degree relatives.
  • Birt–hogg–dubé Syndrome Wikipedia
    Rare autosomal dominant cancer syndrome Birt–Hogg–Dubé syndrome The characteristic fibrofolliculomas of Birt–Hogg–Dubé syndrome seen on a person's face. Specialty Medical genetics Birt–Hogg–Dubé syndrome ( BHD ), also Hornstein–Birt–Hogg–Dubé syndrome , Hornstein–Knickenberg syndrome , and fibrofolliculomas with trichodiscomas and acrochordons [1] is a human autosomal dominant genetic disorder that can cause susceptibility to kidney cancer , renal and pulmonary cysts , and noncancerous tumors of the hair follicles , called fibrofolliculomas . ... They are differentiated with examination of the tumors' histology . [5] Hereditary recurrent pneumothorax or pulmonary cysts are associated with Marfan syndrome , Ehlers–Danlos syndrome , tuberous sclerosis complex (TSC), alpha1-antitrypsin deficiency , and cystic fibrosis . ... Other diseases can mimic the dermatologic manifestations of BHD, including tuberous sclerosis complex, Cowden syndrome , familial trichoepitheliomas , and multiple endocrine neoplasia type 1 . [5] Tuberous sclerosis must be distinguished because both disorders can present with angiofibromas on the face, though they are more common in tuberous sclerosis. [6] Management [ edit ] The different manifestations of Birt–Hogg–Dubé syndrome are controlled in different ways. ... Jelle; De Jong, Daphne; Horenblas, Simon; Ryu, Jay (5 October 2009), "Birt-Hogg-Dubé Syndrome" , in Riegert-Johnson, Douglas L; Boardman, Lisa A; Hefferon, Timothy; Roberts, Maegan (eds.), Cancer Syndromes , Bethesda, MD: National Center for Biotechnology Information, PMID 21249760 Riegert-Johnson, DL, "Birt-Hogg-Dube" , Familial Cancer Syndromes , NCBI , retrieved 21 July 2009 Sudarshan, Sunil; Karam, Jose A.; Brugarolas, James; Thompson, R.
    FLCN, MPRIP, BHD, MET, MTOR, CXCR3, HIF1A, KRT7, TSC1, TSC2, VEGFA, FNIP2, CCM2, SSH2, FNIP1, COPD
    • Birt-Hogg-Dubé Syndrome Gene_reviews
      Hornstein & Knickenberg [1975] described a family with fibrofolliculoma and colorectal polyps. The Hornstein-Knickenberg syndrome is now believed to be identical to BHDS. ... Nomenclature Hornstein-Knickenberg syndrome, which describes familial multiple perifollicular fibromas and fibromata pendulantia, is considered to fall within the spectrum of BHDS [Schulz & Hartschuh 1999]. ... Genes of Interest in the Differential Diagnosis of Birt-Hogg-Dubé Syndrome (BHDS) View in own window Phenotype Gene(s) Disorder MOI Key Clinical Characteristics of Differential Diagnosis Disorder Cutaneous manifestations 1 CYLD 2 Multiple familial trichoepithelioma (see CYLD Cutaneous Syndrome) AD Trichoepitheliomas MEN1 Multiple endocrine neoplasia type 1 AD Facial angiofibromas, collagenomas, lipomas PTEN Cowden syndrome (see PTEN Hamartoma Tumor Syndrome) AD Trichilemmomas, acral keratoses, papillomatous lesions, mucosal lesions TSC1 TSC2 Tuberous sclerosis complex AD Hypomelanotic macules, confetti skin lesions, facial angiofibromas, shagreen patches, fibrous cephalic plaques, ungual fibromas Pulmonary lymphangioleiomyomatosis (may occur as isolated finding or as part of TSC) Lung cysts &/or pneumothorax FBN1 Marfan syndrome AD Lung bullae may develop, especially of the upper lobes; can predispose to spontaneous pneumothorax COL3A1 Vascular Ehlers-Danlos syndrome AD (AR) Spontaneous pneumothoraces may be the 1st significant presenting feature; hemothorax, hemopneumothorax, pulmonary blebs, cystic lesions, & hemorrhagic or fibrous nodules SERPINA1 Alpha1-antitrypsin deficiency AR Chronic obstructive pulmonary disease; emphysema, sometimes w/bronchiectasis CFTR Cystic fibrosis AR Progressive obstructive lung disease w/bronchiectasis Renal cancer 3 VHL von Hippel-Lindau syndrome AD Bilateral & multifocal clear cell renal cell carcinomas; ↑ risk for CNS hemangioblastoma, retinal angioma, pheochromocytoma, & endolymphatic sac tumors MET Hereditary papillary renal cancer (OMIM 605074) AD Bilateral & multifocal type 1 papillary renal cell carcinomas FH Hereditary leiomyomatosis and renal cell cancer AD Usually solitary renal tumors w/histologic spectrum ranging from tubo-papillary renal cell cancer to type 2 papillary renal cancer to collecting duct renal cell cancer; may present w/cutaneous leiomyoma &/or early-onset & aggressive uterine fibroids. MAX SDHA SDHAF2 SDHB SDHC SDHD TMEM127 Hereditary paraganglioma-pheochromocytoma syndromes AD ↑ risk for paragangliomas, pheochromocytomas, gastrointestinal stromal tumors, & RCCs incl oncocytic renal tumors BAP1 BAP1 tumor predisposition syndrome AD Mesothelioma, uveal melanoma, cutaneous melanoma, & different types of renal cell cancer have been described. PTEN Cowden syndrome (see PTEN Hamartoma Tumor Syndrome) AD Benign hamartomas & ↑ risks of breast, thyroid, uterine, renal & other cancers Dermatologic features (e.g., lipomas, trichilemmomas, oral papillomas, penile freckling) AD = autosomal dominant; AR = autosomal recessive; CNS = central nervous system; MOI = mode of inheritance; RCC = renal cell carcinoma; TSC = tuberous sclerosis complex 1.
    • Birt-Hogg-Dube Syndrome Omim
      A number sign (#) is used with this entry because Birt-Hogg-Dube syndrome (BHD), also known as Hornstein-Knickenberg syndrome, is caused by heterozygous mutation in the gene encoding folliculin (FLCN; 607273) on chromosome 17p11. See also primary spontaneous pneumothorax (173600), an allelic disorder that may represent a milder part of the spectrum of the BHD syndrome. Description Birt-Hogg-Dube syndrome is an autosomal dominant genodermatosis characterized by hair follicle hamartomas, kidney tumors, and spontaneous pneumothorax (Nickerson et al., 2002). ... The disorder was distinguished from Gardner syndrome (see 175100). Hornstein and Knickenberg (1975) suggested that patients with follicular fibromatosis be examined for intestinal polyps. ... Kluijt et al. (2009) reported a large Dutch family with BHD syndrome confirmed by genetic analysis (607273.0015). ... Nomenclature Happle (2012) noted that Hornstein and Knickenberg (1975) first described this disorder as 'perifollicular fibromatosis with polyps of the colon--a cutaneo-intestinal syndrome.' Since the designation 'Birt-Hogg-Dube syndrome' is entrenched in the medical literature, it is retained here as the preferred title; 'Hornstein-Knickenberg syndrome' is used here as an alternative title to give credit to the original authors.
    • Birt-Hogg-Dubé Syndrome Orphanet
      Birt-Hogg-Dube (BHD) syndrome is characterized by skin lesions, kidney tumors, and pulmonary cysts that may be associated with pneumothorax. It is a rare clinicopathologic condition named after the three Canadian physicians who reported the syndrome in 1977. Epidemiology The prevalence of BHD is estimated at 1/200,000 but the exact incidence is unknown. ... The cysts rupture under pressure of inhalation, which leads to pneumothorax. Etiology BHD syndrome is transmitted in an autosomal dominant fashion. ... This BHD gene encodes folliculin and although the function of the BHD gene product is still unknown, it is believed to be a component of the mTOR pathway (like other hamartoma syndrome-related proteins) and play a role in the development of renal neoplasms and possibly other associated lesions.
    • Birt-Hogg-Dubé Syndrome Medlineplus
      Birt-Hogg-Dubé syndrome is a rare disorder that affects the skin and lungs and increases the risk of certain types of tumors. Its signs and symptoms vary among affected individuals. Birt-Hogg-Dubé syndrome is characterized by multiple noncancerous (benign) skin tumors, particularly on the face, neck, and upper chest. ... Other types of cancer have also been reported in affected individuals, but it is unclear whether these tumors are actually a feature of Birt-Hogg-Dubé syndrome. Frequency Birt-Hogg-Dubé syndrome is rare; its exact incidence is unknown. ... Causes Mutations in the FLCN gene cause Birt-Hogg-Dubé syndrome. This gene provides instructions for making a protein called folliculin. ... Learn more about the gene associated with Birt-Hogg-Dubé syndrome FLCN Inheritance Pattern This condition is inherited in an autosomal dominant pattern, which means one copy of the altered FLCN gene in each cell is sufficient to cause the disorder.
    • Birt-Hogg-Dube Syndrome Gard
      Birt-Hogg-Dube syndrome (BHDS) is a rare, complex, genetic disorder with three main clinical findings: non-cancerous (benign) skin tumors; lung cysts and/or history of pneumothorax (collapsed lung); and various types of renal tumors.
  • Cherubism Wikipedia
    Cherubism has also been found combined with other genetic disorders including Noonan syndrome , Ramon syndrome , and fragile X syndrome . [7] Mutations of the SH3BP2 gene are only reported in 75% of Cherubism cases. [2] The mutation of the SH3BP2 gene is believed to increase production of over active proteins from this gene. ... External links [ edit ] Classification D ICD - 10 : K10.8 ICD - 9-CM : 526.89 OMIM : 118400 MeSH : D002636 DiseasesDB : 31217 External resources MedlinePlus : 001234 eMedicine : radio/284 Orphanet : 184 v t e Dental disease involving the jaw General Jaw abnormality malocclusion Orthodontics Gnathitis Size Micrognathism Maxillary hypoplasia Maxilla and Mandible Cherubism Congenital epulis Torus mandibularis Torus palatinus Other Jaw and base of cranium Prognathism Retrognathism Dental arch Crossbite Overbite Temporomandibular joint disorder v t e Deficiencies of intracellular signaling peptides and proteins GTP-binding protein regulators GTPase-activating protein Neurofibromatosis type I Watson syndrome Tuberous sclerosis Guanine nucleotide exchange factor Marinesco–Sjögren syndrome Aarskog–Scott syndrome Juvenile primary lateral sclerosis X-Linked mental retardation 1 G protein Heterotrimeic cAMP / GNAS1 : Pseudopseudohypoparathyroidism Progressive osseous heteroplasia Pseudohypoparathyroidism Albright's hereditary osteodystrophy McCune–Albright syndrome CGL 2 Monomeric RAS: HRAS Costello syndrome KRAS Noonan syndrome 3 KRAS Cardiofaciocutaneous syndrome RAB: RAB7 Charcot–Marie–Tooth disease RAB23 Carpenter syndrome RAB27 Griscelli syndrome type 2 RHO: RAC2 Neutrophil immunodeficiency syndrome ARF : SAR1B Chylomicron retention disease ARL13B Joubert syndrome 8 ARL6 Bardet–Biedl syndrome 3 MAP kinase Cardiofaciocutaneous syndrome Other kinase / phosphatase Tyrosine kinase BTK X-linked agammaglobulinemia ZAP70 ZAP70 deficiency Serine/threonine kinase RPS6KA3 Coffin-Lowry syndrome CHEK2 Li-Fraumeni syndrome 2 IKBKG Incontinentia pigmenti STK11 Peutz–Jeghers syndrome DMPK Myotonic dystrophy 1 ATR Seckel syndrome 1 GRK1 Oguchi disease 2 WNK4 / WNK1 Pseudohypoaldosteronism 2 Tyrosine phosphatase PTEN Bannayan–Riley–Ruvalcaba syndrome Lhermitte–Duclos disease Cowden syndrome Proteus-like syndrome MTM1 X-linked myotubular myopathy PTPN11 Noonan syndrome 1 LEOPARD syndrome Metachondromatosis Signal transducing adaptor proteins EDARADD EDARADD Hypohidrotic ectodermal dysplasia SH3BP2 Cherubism LDB3 Zaspopathy Other NF2 Neurofibromatosis type II NOTCH3 CADASIL PRKAR1A Carney complex PRKAG2 Wolff–Parkinson–White syndrome PRKCSH PRKCSH Polycystic liver disease XIAP XIAP2 See also intracellular signaling peptides and proteins
    SH3BP2, TNF, NFATC1, CD68, PTPN11, SYK, CA2, SRC, SH3BP5, USP6, PSTPIP2, TNKS, TNFSF11, RAC1, CALCA, PLEK, PLCG2, PCNA, SERPINE1, FGFR3, CTSK, BAMBI
    • Cherubism Gene_reviews
      The fibroosseous lesions in cherubism are limited to the mandible and maxilla, but the bone inflammatory findings are similar to other autoinflammatory syndromes with bone involvement, such as chronic recurrent multifocal osteomyelitis (CRMO) and deficiency of interleukin-1 receptor antagonist [Wipff et al 2011, Morbach et al 2013, Kadlub et al 2015, Bader-Meunier et al 2018]. ... Disorders to Consider in the Differential Diagnosis of Cherubism View in own window Disorder Gene(s) MOI Clinical Features Overlapping Distinguishing RASopathies 1 including: Noonan syndrome Cardiofaciocutaneous syndrome Neurofibromatosis 1 Noonan syndrome with multiple lentigines BRAF MAP2K1 NF1 PTPN11 SOS1 KRAS LZTR1 MAP2K2 NRAS RAF1 RASA2 RRAS RIT1 SOS2 AD Giant-cell lesions of bones & soft tissues frequently found in jaws RASopathies: Characteristic facial & neurocutaneous findings Congenital anomalies in multiple systems Central giant-cell granuloma 2 Unknown 3 Unknown Benign lesion usually occurring in mandible & maxilla Histologically, central giant-cell granuloma cannot be separated from cherubism. Lesions in: Central giant-cell granuloma: most often unilocular Cherubism: usually multilocular Fibrous Dysplasia / McCune-Albright Syndrome (FD/MAS) GNAS1 See footnote 4 Craniofacial form of FD/MAS may show clinical & radiologic overlap w/cherubism & thus be difficult to differentiate. 5 Fibrous dysplasia: Lesions affecting other body parts incl femur, tibia, or ribs (rarely seen in cherubism) Absence of typical symmetric swelling of lower face (typical of cherubism) On plain films, a characteristic ground-glass pattern MAS: Café au lait macules Endocrine abnormalities Chronic bony involvement that does not resolve at puberty Hyperparathyroidism-jaw tumor (HPT-JT) syndrome (see CDC73 -Related Disorders) CDC73 AD Benign ossifying fibromas of mandible or maxilla Occasionally bilateral/multifocal & recurrent HPT-JT: hyperparathyroidism Familial isolated hyperparathyroidism (OMIM PS145000) CDC73 MEN1 6 CASR GCM2 AD AR Brown tumors (rare benign giant-cell lesions) resulting from parathyroid hormone effects on bone tissue in persons w/hyperparathyroidism Can occur in both maxilla & mandible 7 Hyperparathyroidism: ↑ serum concentrations of calcium, parathyroid hormone, & alkaline phosphatase 6 Ramon syndrome (OMIM 266270) Unknown Unknown Gingival fibromatosis Ramon syndrome: Short stature Epilepsy Intellectual disability AD = autosomal dominant; AR = autosomal recessive; MOI = mode of inheritance; XL = X-linked 1. ... Fibrous dysplasia / McCune-Albright syndrome, a sporadically occurring disorder, is caused by an early embryonic postzygotic somatic activating (gain-of-function) pathogenic variant in GNAS (encoding the cAMP pathway-associated G-protein, Gsα). 5.
    • Cherubism Medlineplus
      For example, cherubism can occur with Ramon syndrome, which also involves short stature, intellectual disability, and overgrowth of the gums (gingival fibrosis ). Additionally, cherubism has been reported in rare cases of Noonan syndrome (a developmental disorder characterized by unusual facial characteristics, short stature, and heart defects) and fragile X syndrome (a condition primarily affecting males that causes learning disabilities and cognitive impairment). ... When cherubism occurs as a feature of a genetic syndrome, it is caused by the same genetic alteration that causes the syndrome.
    • Cherubism Omim
      Quan et al. (1995) described cherubism in association with mental retardation due to mosaicism for expansion and deletion of the FMR1 (309550) CGG repeat, i.e., the fragile X syndrome (300624). Although these were probably independent mutations, Quan et al. (1995) pointed out the peculiarities of the inheritance of cherubism, which has been thought to be an autosomal dominant: twice as many males are affected as females, and whereas penetrance in males is 100%, penetrance in females is only 50 to 70%. ... SH3BP2 lies within a region that is frequently deleted in individuals with Wolf-Hirschhorn syndrome (194190). Haploinsufficiency of SH3BP2 in individuals with that syndrome does not result in cherubism or cherubism-like characteristics.
    • Cherubism Orphanet
      Cherubism can also be part of Ramon syndrome, neurofibromatosis 1 and fragile X syndrome (see these terms). ... Differential diagnosis Differential diagnosis includes Noonan-like syndrome, hyperparathyroidism-jaw tumor syndrome, fibrous dysplasia of bone (see these terms), brown tumor of hyperparathyroidism, and central giant-cell granuloma.
    • Cherubism Gard
      Cherubism is a rare disorder characterized by progressive, painless, bilateral swelling of the jaw during childhood. This fibro-osseous (bone structure) condition is self-limiting, with symptoms typically resolving in adulthood. Diagnosis is based on a combination of clinical signs, family history, radiographic findings (panoramic x-rays, CT scan), biopsy, and genetic testing. Cherubism is inherited in an autosomal dominant fashion and is caused by mutations in the SH3BP2 gene. Treatment tends to be conservative (wait-and-see), with surgery reserved for the most severe cases.
  • Pseudohypoaldosteronism Wikipedia
    TRPV6 may be involved. [2] Presentation [ edit ] PHA2 is clinically characterised by hypertension, hyperkalaemia , metabolic acidosis and normal renal function. [3] Mechanism [ edit ] PHA2 is also known as familial hyperkalaemic hypertension, or Gordon syndrome . The underlying genetic defect leads to increased sodium chloride reabsorption in the distal tubule in the kidney, leading to volume expansion, hypertension and lowered renin levels. ... Alternatively, WNK4 mutations that result in a gain of function of the Na-Cl co-transporter may inhibit ROMK activity resulting in hyperkalemia. [4] Unlike in PHA1 in which aldosterone resistance is present, in PHA2 the volume expansion leads to relatively low aldosterone levels. [3] Treatment [ edit ] Treatment of severe forms of PHA1 requires relatively large amounts of sodium chloride . [5] These conditions also involve hyperkalemia . [6] In contrast, PHA2 (Gordon's syndrome) requires salt restriction and use of thiazide diuretics to block sodium chloride reabsorption and normalise blood pressure and serum potassium. [ citation needed ] History [ edit ] This syndrome was first described by Cheek and Perry in 1958. [7] Later pediatric endocrinologist Aaron Hanukoglu reported that there are two independent forms of PHA with different inheritance patterns: A renal form with autosomal dominant inheritance exhibiting salt loss mainly from the kidneys, and a multi-system form with autosomal recessive form exhibiting salt loss from kidney, lung, and sweat and salivary glands. [8] [9] The hereditary lack of responsiveness to aldosterone could be due to at least two possibilities: 1. ... PMID 20181799 . ^ a b O'Shaughnessy, Kevin M. (November 2015). "Gordon Syndrome: a continuing story". Pediatric Nephrology (Berlin, Germany) . 30 (11): 1903–1908. doi : 10.1007/s00467-014-2956-7 . ... S2CID 9764720 . ^ Pseudohypoaldosteronism at the US National Library of Medicine Medical Subject Headings (MeSH) ^ CHEEK DB, PERRY JW (1958). "A salt wasting syndrome in infancy" . Arch Dis Child . 33 (169): 252–6. doi : 10.1136/adc.33.169.252 . ... External links [ edit ] GeneReviews/NCBI/NIH/UW entry on Pseudohypoaldosteronism Type II Classification D ICD - 10 : N25.8 OMIM : 177735 614495 614491 614496 614492 145260 264350 177735 614495 614491 614496 614492 145260 MeSH : D011546 External resources eMedicine : article/924100 Orphanet : 444916 v t e Adrenal gland disorder Hyperfunction Aldosterone Hyperaldosteronism Primary aldosteronism Conn syndrome Bartter syndrome Glucocorticoid remediable aldosteronism AME Liddle's syndrome 17α CAH Pseudohypoaldosteronism Cortisol Cushing's syndrome Pseudo-Cushing's syndrome Steroid-induced osteoporosis Sex hormones 21α CAH 11β CAH Hypofunction Aldosterone Hypoaldosteronism 21α CAH 11β CAH Cortisol CAH Lipoid 3β 11β 17α 21α Sex hormones 17α CAH Inborn errors of steroid metabolism Adrenal insufficiency Adrenal crisis Adrenalitis Xanthogranulomatous Addison's disease Waterhouse–Friderichsen syndrome v t e Kidney disease Glomerular disease See Template:Glomerular disease Tubules Renal tubular acidosis proximal distal Acute tubular necrosis Genetic Fanconi syndrome Bartter syndrome Gitelman syndrome Liddle's syndrome Interstitium Interstitial nephritis Pyelonephritis Balkan endemic nephropathy Vascular Renal artery stenosis Renal ischemia Hypertensive nephropathy Renovascular hypertension Renal cortical necrosis General syndromes Nephritis Nephrosis Renal failure Acute renal failure Chronic kidney disease Uremia Other Analgesic nephropathy Renal osteodystrophy Nephroptosis Abderhalden–Kaufmann–Lignac syndrome Diabetes insipidus Nephrogenic Renal papilla Renal papillary necrosis Major calyx / pelvis Hydronephrosis Pyonephrosis Reflux nephropathy v t e Genetic disorders relating to deficiencies of transcription factor or coregulators (1) Basic domains 1.2 Feingold syndrome Saethre–Chotzen syndrome 1.3 Tietz syndrome (2) Zinc finger DNA-binding domains 2.1 ( Intracellular receptor ): Thyroid hormone resistance Androgen insensitivity syndrome PAIS MAIS CAIS Kennedy's disease PHA1AD pseudohypoaldosteronism Estrogen insensitivity syndrome X-linked adrenal hypoplasia congenita MODY 1 Familial partial lipodystrophy 3 SF1 XY gonadal dysgenesis 2.2 Barakat syndrome Tricho–rhino–phalangeal syndrome 2.3 Greig cephalopolysyndactyly syndrome / Pallister–Hall syndrome Denys–Drash syndrome Duane-radial ray syndrome MODY 7 MRX 89 Townes–Brocks syndrome Acrocallosal syndrome Myotonic dystrophy 2 2.5 Autoimmune polyendocrine syndrome type 1 (3) Helix-turn-helix domains 3.1 ARX Ohtahara syndrome Lissencephaly X2 MNX1 Currarino syndrome HOXD13 SPD1 synpolydactyly PDX1 MODY 4 LMX1B Nail–patella syndrome MSX1 Tooth and nail syndrome OFC5 PITX2 Axenfeld syndrome 1 POU4F3 DFNA15 POU3F4 DFNX2 ZEB1 Posterior polymorphous corneal dystrophy Fuchs' dystrophy 3 ZEB2 Mowat–Wilson syndrome 3.2 PAX2 Papillorenal syndrome PAX3 Waardenburg syndrome 1&3 PAX4 MODY 9 PAX6 Gillespie syndrome Coloboma of optic nerve PAX8 Congenital hypothyroidism 2 PAX9 STHAG3 3.3 FOXC1 Axenfeld syndrome 3 Iridogoniodysgenesis, dominant type FOXC2 Lymphedema–distichiasis syndrome FOXE1 Bamforth–Lazarus syndrome FOXE3 Anterior segment mesenchymal dysgenesis FOXF1 ACD/MPV FOXI1 Enlarged vestibular aqueduct FOXL2 Premature ovarian failure 3 FOXP3 IPEX 3.5 IRF6 Van der Woude syndrome Popliteal pterygium syndrome (4) β-Scaffold factors with minor groove contacts 4.2 Hyperimmunoglobulin E syndrome 4.3 Holt–Oram syndrome Li–Fraumeni syndrome Ulnar–mammary syndrome 4.7 Campomelic dysplasia MODY 3 MODY 5 SF1 SRY XY gonadal dysgenesis Premature ovarian failure 7 SOX10 Waardenburg syndrome 4c Yemenite deaf-blind hypopigmentation syndrome 4.11 Cleidocranial dysostosis (0) Other transcription factors 0.6 Kabuki syndrome Ungrouped TCF4 Pitt–Hopkins syndrome ZFP57 TNDM1 TP63 Rapp–Hodgkin syndrome / Hay–Wells syndrome / Ectrodactyly–ectodermal dysplasia–cleft syndrome 3 / Limb–mammary syndrome / OFC8 Transcription coregulators Coactivator: CREBBP Rubinstein–Taybi syndrome Corepressor: HR ( Atrichia with papular lesions ) v t e Diseases of ion channels Calcium channel Voltage-gated CACNA1A Familial hemiplegic migraine 1 Episodic ataxia 2 Spinocerebellar ataxia type-6 CACNA1C Timothy syndrome Brugada syndrome 3 Long QT syndrome 8 CACNA1F Ocular albinism 2 CSNB2A CACNA1S Hypokalemic periodic paralysis 1 Thyrotoxic periodic paralysis 1 CACNB2 Brugada syndrome 4 Ligand gated RYR1 Malignant hyperthermia Central core disease RYR2 CPVT1 ARVD2 Sodium channel Voltage-gated SCN1A Familial hemiplegic migraine 3 GEFS+ 2 Febrile seizure 3A SCN1B Brugada syndrome 6 GEFS+ 1 SCN4A Hypokalemic periodic paralysis 2 Hyperkalemic periodic paralysis Paramyotonia congenita Potassium-aggravated myotonia SCN4B Long QT syndrome 10 SCN5A Brugada syndrome 1 Long QT syndrome 3 SCN9A Erythromelalgia Febrile seizure 3B Paroxysmal extreme pain disorder Congenital insensitivity to pain Constitutively active SCNN1B / SCNN1G Liddle's syndrome SCNN1A / SCNN1B / SCNN1G Pseudohypoaldosteronism 1AR Potassium channel Voltage-gated KCNA1 Episodic ataxia 1 KCNA5 Familial atrial fibrillation 7 KCNC3 Spinocerebellar ataxia type-13 KCNE1 Jervell and Lange-Nielsen syndrome Long QT syndrome 5 KCNE2 Long QT syndrome 6 KCNE3 Brugada syndrome 5 KCNH2 Short QT syndrome KCNQ1 Jervell and Lange-Nielsen syndrome Romano–Ward syndrome Short QT syndrome Long QT syndrome 1 Familial atrial fibrillation 3 KCNQ2 BFNS1 Inward-rectifier KCNJ1 Bartter syndrome 2 KCNJ2 Andersen–Tawil syndrome Long QT syndrome 7 Short QT syndrome KCNJ11 TNDM3 KCNJ18 Thyrotoxic periodic paralysis 2 Chloride channel CFTR Cystic fibrosis Congenital absence of the vas deferens CLCN1 Thomsen disease Myotonia congenita CLCN5 Dent's disease CLCN7 Osteopetrosis A2, B4 BEST1 Vitelliform macular dystrophy CLCNKB Bartter syndrome 3 TRP channel TRPC6 FSGS2 TRPML1 Mucolipidosis type IV Connexin GJA1 Oculodentodigital dysplasia Hallermann–Streiff syndrome Hypoplastic left heart syndrome GJB1 Charcot–Marie–Tooth disease X1 GJB2 Keratitis–ichthyosis–deafness syndrome Ichthyosis hystrix Bart–Pumphrey syndrome Vohwinkel syndrome ) GJB3 / GJB4 Erythrokeratodermia variabilis Progressive symmetric erythrokeratodermia GJB6 Clouston's hidrotic ectodermal dysplasia Porin AQP2 Nephrogenic diabetes insipidus 2 See also: ion channels v t e Deficiencies of intracellular signaling peptides and proteins GTP-binding protein regulators GTPase-activating protein Neurofibromatosis type I Watson syndrome Tuberous sclerosis Guanine nucleotide exchange factor Marinesco–Sjögren syndrome Aarskog–Scott syndrome Juvenile primary lateral sclerosis X-Linked mental retardation 1 G protein Heterotrimeic cAMP / GNAS1 : Pseudopseudohypoparathyroidism Progressive osseous heteroplasia Pseudohypoparathyroidism Albright's hereditary osteodystrophy McCune–Albright syndrome CGL 2 Monomeric RAS: HRAS Costello syndrome KRAS Noonan syndrome 3 KRAS Cardiofaciocutaneous syndrome RAB: RAB7 Charcot–Marie–Tooth disease RAB23 Carpenter syndrome RAB27 Griscelli syndrome type 2 RHO: RAC2 Neutrophil immunodeficiency syndrome ARF : SAR1B Chylomicron retention disease ARL13B Joubert syndrome 8 ARL6 Bardet–Biedl syndrome 3 MAP kinase Cardiofaciocutaneous syndrome Other kinase / phosphatase Tyrosine kinase BTK X-linked agammaglobulinemia ZAP70 ZAP70 deficiency Serine/threonine kinase RPS6KA3 Coffin-Lowry syndrome CHEK2 Li-Fraumeni syndrome 2 IKBKG Incontinentia pigmenti STK11 Peutz–Jeghers syndrome DMPK Myotonic dystrophy 1 ATR Seckel syndrome 1 GRK1 Oguchi disease 2 WNK4 / WNK1 Pseudohypoaldosteronism 2 Tyrosine phosphatase PTEN Bannayan–Riley–Ruvalcaba syndrome Lhermitte–Duclos disease Cowden syndrome Proteus-like syndrome MTM1 X-linked myotubular myopathy PTPN11 Noonan syndrome 1 LEOPARD syndrome Metachondromatosis Signal transducing adaptor proteins EDARADD EDARADD Hypohidrotic ectodermal dysplasia SH3BP2 Cherubism LDB3 Zaspopathy Other NF2 Neurofibromatosis type II NOTCH3 CADASIL PRKAR1A Carney complex PRKAG2 Wolff–Parkinson–White syndrome PRKCSH PRKCSH Polycystic liver disease XIAP XIAP2 See also intracellular signaling peptides and proteins
    KLHL3, NR3C2, SCNN1A, SCNN1B, SCNN1G, WNK4, WNK1, GNAS, STX16, GNAS-AS1, CUL3, REN, ASIC5, TNF, NR4A1, CLDN8, MRC1, KCNJ1, SGK1
  • Joubert Syndrome Wikipedia
    Joubert syndrome Other names CPD IV [1] Joubert syndrome is inherited via an autosomal recessive manner Specialty Medical genetics Joubert syndrome is a rare autosomal recessive genetic disorder that affects the cerebellum , an area of the brain that controls balance and coordination. ... Rarely, Joubert syndrome is inherited in an X-linked recessive pattern. ... The cilia defects adversely affect "numerous critical developmental signaling pathways" essential to cellular development and thus offer a plausible hypothesis for the often multi-symptom nature of a large set of syndromes and diseases. [ citation needed ] Currently recognized ciliopathies include Joubert syndrome, primary ciliary dyskinesia (also known as Kartagener Syndrome), Bardet–Biedl syndrome , polycystic kidney disease and polycystic liver disease , nephronophthisis , Alström syndrome , Meckel–Gruber syndrome and some forms of retinal degeneration . [17] Joubert syndrome type 2 is disproportionately frequent among people of Jewish descent . [18] References [ edit ] ^ RESERVED, INSERM US14-- ALL RIGHTS. ... "Joubert syndrome with associated corpus callosum agenesis". ... External links [ edit ] Classification D ICD - 10 : Q04.3 ICD - 9-CM : 742.2 OMIM : 213300 DiseasesDB : 30688 External resources GeneReviews : Joubert Syndrome and Related Disorders Orphanet : 475 NINDS Joubert Syndrome Information Page Researchers Identify Joubert Syndrome Genes GeneReviews: Joubert syndrome NCBI Joubert Syndrome v t e Diseases of cilia Structural receptor: Polycystic kidney disease cargo: Asphyxiating thoracic dysplasia basal body : Bardet–Biedl syndrome mitotic spindle : Meckel syndrome centrosome : Joubert syndrome Signaling Nephronophthisis Other/ungrouped Alström syndrome Primary ciliary dyskinesia Senior–Løken syndrome Orofaciodigital syndrome 1 McKusick–Kaufman syndrome Autosomal recessive polycystic kidney See also: ciliary proteins v t e Deficiencies of intracellular signaling peptides and proteins GTP-binding protein regulators GTPase-activating protein Neurofibromatosis type I Watson syndrome Tuberous sclerosis Guanine nucleotide exchange factor Marinesco–Sjögren syndrome Aarskog–Scott syndrome Juvenile primary lateral sclerosis X-Linked mental retardation 1 G protein Heterotrimeic cAMP / GNAS1 : Pseudopseudohypoparathyroidism Progressive osseous heteroplasia Pseudohypoparathyroidism Albright's hereditary osteodystrophy McCune–Albright syndrome CGL 2 Monomeric RAS: HRAS Costello syndrome KRAS Noonan syndrome 3 KRAS Cardiofaciocutaneous syndrome RAB: RAB7 Charcot–Marie–Tooth disease RAB23 Carpenter syndrome RAB27 Griscelli syndrome type 2 RHO: RAC2 Neutrophil immunodeficiency syndrome ARF : SAR1B Chylomicron retention disease ARL13B Joubert syndrome 8 ARL6 Bardet–Biedl syndrome 3 MAP kinase Cardiofaciocutaneous syndrome Other kinase / phosphatase Tyrosine kinase BTK X-linked agammaglobulinemia ZAP70 ZAP70 deficiency Serine/threonine kinase RPS6KA3 Coffin-Lowry syndrome CHEK2 Li-Fraumeni syndrome 2 IKBKG Incontinentia pigmenti STK11 Peutz–Jeghers syndrome DMPK Myotonic dystrophy 1 ATR Seckel syndrome 1 GRK1 Oguchi disease 2 WNK4 / WNK1 Pseudohypoaldosteronism 2 Tyrosine phosphatase PTEN Bannayan–Riley–Ruvalcaba syndrome Lhermitte–Duclos disease Cowden syndrome Proteus-like syndrome MTM1 X-linked myotubular myopathy PTPN11 Noonan syndrome 1 LEOPARD syndrome Metachondromatosis Signal transducing adaptor proteins EDARADD EDARADD Hypohidrotic ectodermal dysplasia SH3BP2 Cherubism LDB3 Zaspopathy Other NF2 Neurofibromatosis type II NOTCH3 CADASIL PRKAR1A Carney complex PRKAG2 Wolff–Parkinson–White syndrome PRKCSH PRKCSH Polycystic liver disease XIAP XIAP2 See also intracellular signaling peptides and proteins
    INPP5E, AHI1, CPLANE1, TMEM67, KIAA0586, MKS1, PIBF1, TCTN1, TCTN2, CSPP1, CEP104, CEP41, ARMC9, TMEM237, HYLS1, ARL13B, RPGRIP1L, KIAA0753, KIAA0556, TMEM231, TMEM216, B9D2, B9D1, KIF7, CEP120, ARL3, TCTN3, FAM149B1, POC1B, TMEM138, ZIC1, CEP290, CC2D2A, OFD1, PDE6D, ITPR1, RCOR1, RNU4ATAC, ALX4, MVK, MEF2C, TFAP2A, IFT172, LRRCC1, C2CD3, NPHP1, LPO, CLUAP1, INVS, ARL13A, NPHP4, TMEM107, WNT1, CELSR2, BARHL1, BPIFA4P, ITFG1, TIPRL, PPP1R21, LCA5, METTL8, RPGRIP1, ANPEP, CHD7, SUFU, ATF4, CCND1, CSF2, TIMM8A, DVL1, FGF8, GYS2, INPP5B, JBS, LAMC2, RAC2, RASA1, RASGRF1, SMO, SOS1, TULP3, ZNF131, MKKS, MLRL, SYNJ1, SYNJ2, HAP1, ADGRG1, RGS6, KAT5, ZNF423, DMXL2, NXPH1, CEND1, LCA10
    • Joubert Syndrome Gene_reviews
      ADPKD = autosomal dominant polycystic kidney disease; JS-JATD = Jeune asphyxiating thoracic dystrophy; LCA = Leber congenital amaurosis; MKS = Meckel syndrome; NPHP = nephronophthisis; OFD = oral-facial-digital syndrome 1. ... JS Clinical Subtypes See Table 2 and Table 3. Table 2. Joubert Syndrome: Clinical Subtypes View in own window Name of Clinical Subtype Mandatory Features in Addition to Primary Criteria 1 Strongly Associated Features 2 Other Names Genes (bold = major gene) Classic or pure Joubert syndrome JS; JS type A Many genes Joubert syndrome w/retinal disease (JS-Ret) Retinal dystrophy (including LCA) JS type B AHI1 CEP290 CEP41 INPP5E MKS1 TMEM107 TMEM138 TMEM216 Joubert syndrome w/renal disease (JS-Ren) NPHP (includes cystic kidney disease) AHI1 CC2D2A CEP290 NPHP1 OFD1 RPGRIP1L TMEM138 TMEM216 TMEM237 ZNF423 Joubert syndrome w/oculorenal disease (JS-OR) Retinal dystrophy (incl LCA); NPHP CHF (occasional) JS type B; CORS; Senior-Løken syndrome; Dekaban-Arima syndrome AHI1 CC2D2A CEP290 NPHP1 POC1B RPGRIP1L TMEM216 TMEM231 TMEM237 Joubert syndrome w/hepatic disease (JS-H) CHF Colobomas; NPHP COACH syndrome; Gentile syndrome CC2D2A CEP290 INPP5E RPGRIP1L TMEM67 Joubert syndrome w/oral-facial-digital features (JS-OFD) Tongue hamartomas; oral frenulae; polydactyly 3 Cleft lip/palate Varadi-Papp syndrome; OFD VI; OFD IV; Mohr-Majewski syndrome B9D2 C2CD3 CPLANE1 CEP120 KIF7 OFD1 TCTN2 TCTN3 TMEM107 TMEM216 Joubert syndrome w/acro-callosal features (JS-AC) Agenesis of corpus callosum; polydacyly 3 Hydrocephalus Acrocallosal syndrome KIF7 Joubert syndrome w/Jeune asphyxiating thoracic dystrophy features (JS-JATD) Skeletal dysplasia (short ribs, small thorax, short limbs, renal cystic disease) Polydactyly 3 ; cone-shaped epiphyses; CHF Jeune asphyxiating thoracic dystrophy; Mainzer-Saldino syndrome CEP120 CSPP1 IFT172 KIAA0586 Adapted from Brancati et al [2010]. ... Joubert syndrome with oral-facial-digital features (JS-OFD). ... Joubert syndrome with Jeune asphyxiating thoracic dystrophy (JS-JATD). ... Nonetheless, many observers report a "Joubert syndrome facies" [Braddock et al 2007].
    • Joubert Syndrome Gard
      Joubert syndrome is disorder of brain development that may affect many parts of the body. ... Various other abnormalities may also be present. Joubert syndrome may be caused by mutations in any of many genes.
  • Cadasil Wikipedia
    CADASIL Other names CADASIL syndrome Brain MRI from patients with CADASIL showing multiple lesions. Specialty Neurology , cardiology , medical genetics CADASIL or CADASIL syndrome , involving cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy , is the most common form of hereditary stroke disorder, and is thought to be caused by mutations of the Notch 3 gene on chromosome 19 . [1] The disease belongs to a family of disorders called the leukodystrophies . ... The mean age of onset of ischemic episodes is approximately 46 years (range 30–70). A classic lacunar syndrome occurs in at least two-thirds of affected patients while hemispheric strokes are much less common. ... Further reading [ edit ] Wikimedia Commons has media related to CADASIL syndrome . Lesnik Oberstein SA, Boon EM, Terwindt GM (June 28, 2012). ... External links [ edit ] cureCADASIL (US) [1] CADASIL Support UK [2] asociacion cadasil espana (Spain) [3] United Leukodystrophy Foundation: CADASIL A patient story at The New York Times Classification D ICD - 10 : I67.850 OMIM : 125310 MeSH : D046589 DiseasesDB : 2161 External resources Patient UK : CADASIL GeneReviews : CADASIL Orphanet : 136 v t e Cerebrovascular diseases including stroke Ischaemic stroke Brain Anterior cerebral artery syndrome Middle cerebral artery syndrome Posterior cerebral artery syndrome Amaurosis fugax Moyamoya disease Dejerine–Roussy syndrome Watershed stroke Lacunar stroke Brain stem Brainstem stroke syndrome Medulla Medial medullary syndrome Lateral medullary syndrome Pons Medial pontine syndrome / Foville's Lateral pontine syndrome / Millard-Gubler Midbrain Weber's syndrome Benedikt syndrome Claude's syndrome Cerebellum Cerebellar stroke syndrome Extracranial arteries Carotid artery stenosis precerebral Anterior spinal artery syndrome Vertebrobasilar insufficiency Subclavian steal syndrome Classification Brain ischemia Cerebral infarction Classification Transient ischemic attack Total anterior circulation infarct Partial anterior circulation infarct Other CADASIL Binswanger's disease Transient global amnesia Haemorrhagic stroke Extra-axial Epidural Subdural Subarachnoid Cerebral/Intra-axial Intraventricular Brainstem Duret haemorrhages General Intracranial hemorrhage Aneurysm Intracranial aneurysm Charcot–Bouchard aneurysm Other Cerebral vasculitis Cerebral venous sinus thrombosis v t e Deficiencies of intracellular signaling peptides and proteins GTP-binding protein regulators GTPase-activating protein Neurofibromatosis type I Watson syndrome Tuberous sclerosis Guanine nucleotide exchange factor Marinesco–Sjögren syndrome Aarskog–Scott syndrome Juvenile primary lateral sclerosis X-Linked mental retardation 1 G protein Heterotrimeic cAMP / GNAS1 : Pseudopseudohypoparathyroidism Progressive osseous heteroplasia Pseudohypoparathyroidism Albright's hereditary osteodystrophy McCune–Albright syndrome CGL 2 Monomeric RAS: HRAS Costello syndrome KRAS Noonan syndrome 3 KRAS Cardiofaciocutaneous syndrome RAB: RAB7 Charcot–Marie–Tooth disease RAB23 Carpenter syndrome RAB27 Griscelli syndrome type 2 RHO: RAC2 Neutrophil immunodeficiency syndrome ARF : SAR1B Chylomicron retention disease ARL13B Joubert syndrome 8 ARL6 Bardet–Biedl syndrome 3 MAP kinase Cardiofaciocutaneous syndrome Other kinase / phosphatase Tyrosine kinase BTK X-linked agammaglobulinemia ZAP70 ZAP70 deficiency Serine/threonine kinase RPS6KA3 Coffin-Lowry syndrome CHEK2 Li-Fraumeni syndrome 2 IKBKG Incontinentia pigmenti STK11 Peutz–Jeghers syndrome DMPK Myotonic dystrophy 1 ATR Seckel syndrome 1 GRK1 Oguchi disease 2 WNK4 / WNK1 Pseudohypoaldosteronism 2 Tyrosine phosphatase PTEN Bannayan–Riley–Ruvalcaba syndrome Lhermitte–Duclos disease Cowden syndrome Proteus-like syndrome MTM1 X-linked myotubular myopathy PTPN11 Noonan syndrome 1 LEOPARD syndrome Metachondromatosis Signal transducing adaptor proteins EDARADD EDARADD Hypohidrotic ectodermal dysplasia SH3BP2 Cherubism LDB3 Zaspopathy Other NF2 Neurofibromatosis type II NOTCH3 CADASIL PRKAR1A Carney complex PRKAG2 Wolff–Parkinson–White syndrome PRKCSH PRKCSH Polycystic liver disease XIAP XIAP2 See also intracellular signaling peptides and proteins
    NOTCH3, HTRA1, EGF, COL4A1, COL18A1, NOTCH1, JAG1, APOE, APP, LPA, TREX1, GFAP, PLXNA2, CTSA, PROC, ACTB, SOD1, TGFB1, NOTCH2, LAP, MRS2, RNF213, NOX5, THBD, KDR, NEFL, ACTG2, RBPJ, FN1, FBN1, ELN, DVL1, DCN, CSF3, CSF1R, CLU, CACNA1A, BGN, APCS, LINC01191
    • Cadasil Gene_reviews
      Ischemic episodes typically present as a classic lacunar syndrome (pure motor stroke, ataxic hemiparesis/dysarthria-clumsy hand syndrome, pure sensory stroke, sensorimotor stroke), but other lacunar syndromes (brain stem or hemispheric) are also observed [Adib-Samii et al 2010].
    • Cerebral Autosomal Dominant Arteriopathy-Subcortical Infarcts-Leukoencephalopathy Orphanet
      Differential diagnosis Differential diagnoses include Binswanger disease, primary angiitis of the central nervous system and multiple sclerosis as well as other genetic disorders such as CARASIL, MELAS syndrome, Fabry disease and small-vessel diseases associated with COL4A1 mutations (e.g. familial porencephaly) (see these terms).
    • Cerebral Arteriopathy, Autosomal Dominant, With Subcortical Infarcts And Leukoencephalopathy, Type 1 Omim
      A number sign (#) is used with this entry because of evidence that autosomal dominant cerebral arteriopathy with subcortical infarcts and leukoencephalopathy type 1 (CADASIL1) is caused by heterozygous mutation in the NOTCH3 gene (600276) on chromosome 19p13. Description Autosomal dominant cerebral arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a progressive disorder of the small arterial vessels of the brain manifest by migraine, strokes, and white matter lesions, with resultant cognitive impairment in some patients (review by Kalimo et al., 1999). Clinical Features Stevens et al. (1977) reported an English family with onset of recurrent cerebral ischemic strokes between 39 and 57 years resulting in progressive neurologic dysfunction and eventual dementia. Affected individuals did not have hypertension, diabetes, or increased cholesterol, but neuropathologic investigation showed abnormalities of the cerebral vasculature; the authors suggested that it was a form of 'vascular encephalopathy.' Low et al. (2007) provided a follow-up of the family reported by Stevens et al. (1977), including confirmation of the CADASIL diagnosis by identification of a pathogenic mutation in the NOTCH3 gene (see MOLECULAR GENETICS).
    • Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts And Leukoencephalopathy Medlineplus
      Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, usually called CADASIL, is an inherited condition that causes stroke and other impairments. This condition affects blood flow in small blood vessels , particularly cerebral vessels within the brain. The muscle cells surrounding these blood vessels (vascular smooth muscle cells ) are abnormal and gradually die. In the brain, the resulting blood vessel damage (arteriopathy) can cause migraines, often with visual sensations or auras, or recurrent seizures (epilepsy). Damaged blood vessels reduce blood flow and can cause areas of tissue death (infarcts) throughout the body.
    • Cadasil Gard
      CADASIL (Cerebral Autosomal Dominant Arteriopathy with Sub-cortical Infarcts and Leukoencephalopathy) is an inherited disease of the blood vessels that occurs when the thickening of blood vessel walls blocks the flow of blood to the brain. The disease primarily affects the small blood vessels in the white matter of the brain. CADASIL is characterized by migraine headaches and multiple strokes , which progresses to dementia. Other symptoms include white matter lesions throughout the brain, cognitive deterioration, seizures, vision problems, and psychiatric problems such as severe depression and changes in behavior and personality. Individuals may also be at higher risk of heart attack. Symptoms and disease onset vary widely, with signs typically appearing in the mid-30s.
  • ←
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • ...
  • 556
  • 557
  • →

FindZebra

contact@findzebra.com